methamphetamine has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 450 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (1.56) | 18.7374 |
| 1990's | 40 (8.89) | 18.2507 |
| 2000's | 155 (34.44) | 29.6817 |
| 2010's | 187 (41.56) | 24.3611 |
| 2020's | 61 (13.56) | 2.80 |
| Authors | Studies |
|---|---|
| Gilmour, B; Lewin, AH; Miller, GM | 1 |
| Glennon, RA | 1 |
| Elayan, I; Foltz, RL; Gibb, JW; Hanson, GR; Johnson, M; Lim, HK | 1 |
| Nash, JF; Yamamoto, BK | 1 |
| Azmitia, EC; Berger, UV; Gu, XF | 1 |
| Glennon, RA; Higgs, R | 1 |
| Farfel, GM; Seiden, LS; Vosmer, GL | 1 |
| Chei, DM; Foltz, RL; Lim, HK; Zeng, S | 1 |
| Gibb, JW; Hanson, GR; Johnson, M; Mitros, K; Stone, DM; Zobrist, R | 1 |
| Katz, JL; Ricaurte, GA; Steele, TD | 1 |
| Black, CK; Schmidt, CJ; Taylor, VL | 1 |
| Virus, RM; Woolverton, WL; Zacny, JP | 1 |
| Gibb, JW; Hanson, GR; Johnson, M | 3 |
| Gibb, JW; Hanson, GR; Stahl, DC; Stone, DM | 1 |
| Bush, L; Gibb, JW; Hanson, GR; Johnson, M; Letter, A; Merchant, KM; Sonsalla, P | 1 |
| Brady, JF; Cho, AK; Di Stefano, EW | 1 |
| Fitzgerald, RL; Poklis, A; Ramos, JM | 1 |
| Bush, L; Gibb, JW; Hanson, GR; Letter, AA; Merchant, KM | 1 |
| Cirimele, V; Kintz, P; Mangin, P; Tracqui, A | 1 |
| Heller, A; Heller, B; Hoffmann, PC; Won, L | 1 |
| Cadet, JL; Cerruti, C; Epstein, CJ; Ladenheim, B; Sheng, P | 1 |
| Davies, KG; Neal, JW; Selmi, F; Sharma, RR | 1 |
| Dasgupta, A; Thompson, WC | 1 |
| Calder, L; Clikeman, J; Finnegan, KT; Karler, R; Wei, S | 1 |
| Castagna, F; Ferrara, SD; Frison, G; Giorgetti, R; Tedeschi, L | 1 |
| Miller, DB; O'Callaghan, JP | 1 |
| Finnegan, KT; Taraska, T | 2 |
| Sabol, KE; Seiden, LS | 1 |
| Fay, J; Fogerson, R; Niedbala, RS; Schoendorfer, D; Spiehler, V | 1 |
| Bourquin, D; Bracher, K; Brenneisen, R; Helmlin, HJ; Vonlanthen, D | 1 |
| Onwudike, M | 1 |
| Barni Comparini, I; Centini, F; Masti, A | 1 |
| Kikura, R; Mieczkowski, T; Nakahara, Y; Tagliaro, F | 1 |
| Brenneisen, R; Lanz, M; Thormann, W | 1 |
| Cho, AK; Di Stefano, EW; Ellis, SW; Hsu, L; Lennard, MS; Lin, LY; Schmitz, DA; Tucker, GT | 1 |
| Cadet, JL; Hirata, H; Ladenheim, B; Mann, H; Moran, TH | 1 |
| Brannock, C; Cadet, JL | 1 |
| Ahmed, JM; Oakley, GD; Salame, MY | 1 |
| Fleckenstein, AE; Gibb, JW; Hanson, GR; Metzger, RR | 1 |
| Tretter, F | 1 |
| Byard, RW; Gilbert, J; James, R; Lokan, RJ | 1 |
| Anthony, PP; Beaman, M; Bingham, C; Nicholls, AJ | 1 |
| Hanson, GR; Westwood, SC | 1 |
| Krieg, JC; Mennel, HD; Schäfer, T; Schlegel, J; Stumm, G; Vedder, H; Würz, C | 1 |
| Hanson, GR; Jensen, M; Johnson, M; White, HS | 1 |
| Cody, JT; Hensley, D | 1 |
| Baumann, MH; Carroll, FI; Dersch, CM; Partilla, JS; Rice, KC; Rothman, RB | 1 |
| Brenneisen, R; Camí, J; de la Torre, R; Farré, M; Mas, M; Ortuño, J; Roset, PN; Segura, J | 1 |
| Allen, DL; Cooper, GA; Ditton, J; Oliver, JS; Scott, KS; Smith, ID | 1 |
| Burrows, KB; Gudelsky, G; Yamamoto, BK | 1 |
| Dawson, M; Kannangara, GS; Lee, GS; Taylor, RC; Wilson, MA | 1 |
| Benkovic, S; Gordon, MN; Miller, D; O'Callaghan, JP; Pennypacker, KR; Yang, X | 1 |
| Dal Cason, TA | 1 |
| Brehm, G; Sägmüller, B; Schneider, S; Schwarze, B | 1 |
| Harris, LS | 1 |
| Brown, JM; Fleckenstein, AE; Gibb, JW; Hansen, JP; Hanson, GR; Riddle, EL; Sandoval, V | 1 |
| Dukat, M; Glennon, RA; Young, R | 1 |
| Camí, J; de la Torre, R; Farré, M; Hernández-López, C; Joglar, J; Llebaria, A; Mas, M; Ortuño, J; Pizarro, N; Pujadas, M; Roset, PN; Segura, J | 1 |
| Ali, SF; Blough, B; Gough, B; Imam, SZ; Slikker, W | 1 |
| Barnett, DA; Ells, B; Guevremont, R; McCooeye, MA; Mester, Z; Purves, RW | 1 |
| Freese, TE; Miotto, K; Reback, CJ | 1 |
| Tellier, PP | 1 |
| Dryhurst, G; Jiang, XR | 1 |
| Cooper, DP; De Boeck, G; De Bruijn, EA; Maes, RA; Morris, M; Samyn, N; Wood, M | 1 |
| Camarasa, J; Camins, A; Canudas, AM; Escubedo, E; Pallàs, M; Pubill, D | 1 |
| Fürst, S; Gyarmati, S; Szabó, A; Timár, J | 1 |
| Huang, Z; Zhang, S | 1 |
| Knight, J | 1 |
| Holden, C | 1 |
| Barnard, ND | 1 |
| Capobianco, L; De Blasi, A; Ferrucci, M; Fornai, F; Gesi, M; Lazzeri, G; Lenzi, P; Paparelli, A; Pellegrini, A; Ruggieri, S; Soldani, P | 1 |
| Hsu, J; Li, JH; Lin, DL; Liu, C; Liu, CP; Liu, RH; Tsay, WI | 1 |
| Kishimoto, H | 1 |
| de la Torre, R; Farré, M; Menoyo, E; Pichini, S; Poudevida, S; Pujadas, M; Zuccaro, P | 1 |
| Fendrich, M; Hubbell, A; Johnson, TP; Wislar, JS | 1 |
| Dermatis, H; Galanter, M; Lee, SJ; McDowell, D | 1 |
| Horn, CK; Klette, KL; Stout, PR | 1 |
| Caruso, MJ; Delgado, JH; Honigman, B; Stillman, D; Waksman, JC | 1 |
| Clemens, KJ; Cornish, JL; Hunt, GE; Li, KM; McGregor, IS; Van Nieuwenhuyzen, PS | 1 |
| Fantegrossi, WE; Hatzidimitriou, G; Kilbourn, M; Ricaurte, GA; Sherman, P; Winger, G; Woods, JH; Woolverton, WL; Yuan, J | 1 |
| Baucum, AJ; Fleckenstein, AE; Hanson, GR; Rau, KS; Riddle, EL | 1 |
| Katagi, M; Miki, A; Shima, N; Tsuchihashi, H | 1 |
| Camarasa, J; Camins, A; Canudas, AM; Escubedo, E; Jiménez, A; Jordà, EG; Pallàs, M; Pubill, D; Sureda, FX; Verdaguer, E | 1 |
| Klein, M; Kramer, F | 1 |
| Cuddy, ML | 1 |
| Bassetto, F; Castagna, F; Dall'Olio, G; Marchioro, L; Plebani, M; Tedeschi, L | 1 |
| Hogg, RS; Lampinen, TM; Rusch, M; Schilder, A | 1 |
| Dowgiert, J; Francescutti-Verbeem, D; Geddes, TJ; Kuhn, DM; Liu, X; Thomas, DM | 1 |
| Mallett, NM; Mills, E; Rusyniak, DE; Sprague, JE | 1 |
| Achat-Mendes, C; Itzhak, Y | 1 |
| Hugel, J; Kalasinsky, KS; Kish, SJ | 1 |
| Armstrong, BD; Noguchi, KK | 1 |
| Jacobs, A; Jemionek, J; Lesser, D; Paul, BD; Searles, DA | 1 |
| Ali, SF; Anderson, KL; Itzhak, Y | 1 |
| Kennedy, CL; Parks, KA | 1 |
| Magrané, M; Royo-Isach, J; Ruiz, L; Velilla, A | 1 |
| Achat-Mendes, C; Ali, SF; Itzhak, Y | 1 |
| Cooper, GJ; Sheridan, RD; Tattersall, JE; Turner, SR | 1 |
| Clemens, KJ; Cornish, JL; Hunt, GE; Li, KM; McGregor, IS | 1 |
| Clatts, MC; Goldsamt, LA; Yi, H | 1 |
| Callaghan, PD; Felgate, P; Irvine, RJ; Keane, M; McCann, UD; White, JM | 1 |
| Bondareva, T; Glennon, RA; Khorana, N; Young, R | 1 |
| Rodriguez-Cruz, SE | 1 |
| Bossong, MG; Niesink, RJ; Van Dijk, JP | 1 |
| Bruno, R; Day, C; Degenhardt, L; Fry, C; Johnston, J; Kinner, S; White, B | 1 |
| Blanchard, D; Danger, Y; Devys, A; Folléa, G; Gadjou, C; Galons, H | 1 |
| Dietzen, DJ; Koenig, JW; Moyer, TP; Saunders, AN; Turk, J; Woodworth, A | 1 |
| Galvin, DM; Schlenger, WE; Wu, LT | 1 |
| Lampinen, TM; Martin, I; McGhee, D | 1 |
| Huestis, MA; Scheidweiler, KB | 1 |
| Jeng, W; Parman, T; Ramkissoon, A; Wells, PG | 1 |
| Colfax, G; Guzman, R | 1 |
| Kelly, BC; Parsons, JT; Wells, BE | 1 |
| Baumann, MH; Rothman, RB; Zolkowska, D | 1 |
| Jansen, KL; Theron, L | 1 |
| Chung, H; Martins, LF; Wennig, R; Yegles, M | 1 |
| Firth, AY | 1 |
| Quinton, MS; Yamamoto, BK | 1 |
| Johansen, SS; Olsen, KH; Rasmussen, LB | 1 |
| Abraham, TT; Huestis, MA; Pirnay, SO | 1 |
| Chen, DD; Fang, N; Liu, H; Meng, P; Wang, M | 1 |
| Chung, H; Han, E; Kim, E; Lee, J; Lee, S; Lim, M; Park, Y; Yang, W | 1 |
| Crean, RD; Davis, SA; Katner, SN; Lay, CC; Taffe, MA; Von Huben, SN | 1 |
| Cheng Liu, M; Gold, MS; Hayes, RL; Kobeissy, FH; Larner, SF; Wang, KK; Warren, MW; Zheng, W | 1 |
| Clemens, KJ; Cornish, JL; Hunt, GE; McGregor, IS | 3 |
| Bruce, CC; Dalley, JW; Everitt, BJ; Huszar, AC; Lääne, K; Peña, Y; Robbins, TW; Theobald, DE; Wojcieszek, M | 1 |
| Wang, Z; Woolverton, WL | 1 |
| Coolen, LM; Gudelsky, GA; Straiko, MM; Zemlan, FP | 1 |
| Gold, MS; Hayes, RL; Kobeissy, FH; Liu, MC; Wang, KK; Warren, MW | 1 |
| Baccini, C; Bugamelli, F; Cavallini, A; Conti, M; Mandrioli, R; Raggi, MA | 1 |
| Abraham, TT; Huestis, MA; Lowe, RH; Pirnay, SO | 1 |
| Brown, SD; Pritchard, BJ; Rhodes, DJ | 1 |
| Chang-Fong, J; Dukat, M; El-Zahabi, M; Glennon, RA; Young, R | 1 |
| Cox, C; Jacobson, LP; Li, X; Ostrow, DG; Peck, JA; Plankey, MW; Stall, R | 1 |
| Ikeda, K; Iwamura, T; Kobayashi, T; Nishizawa, D | 1 |
| Lenné, MG | 1 |
| Büchler, J; Kovar, KA; Putzke, J; Smalla, KH; Spina, MG; Wolf, G | 1 |
| Cadet, JL; Jayanthi, S; Krasnova, IN; Lyles, J | 1 |
| Crean, RD; Davis, SA; Taffe, MA | 1 |
| Irvine, RJ; Jaehne, EJ; Salem, A | 1 |
| Cooper, G; Hand, C; Jehanli, A; Smith, R; Wilson, L | 1 |
| Cody, JT; Phelix, CF; Valtier, S | 1 |
| Camarasa, J; Escubedo, E; Garcia-Ratés, S; Pubill, D | 1 |
| Inoue, H; Iwata, Y; Kamo, N; Kanamori, T; Kishi, T; Kuwayama, K; Miyaguchi, H; Miyauchi, S; Tsujikawa, K | 1 |
| Kamata, H; Katagi, M; Nemoto, N; Sakuma, T; Shima, N; Tsuchihashi, H | 1 |
| Maurer, HH; Mueller, M; Peters, FT; Ricaurte, GA | 2 |
| Brezing, CA; Gold, MS; Hayes, RL; Jeung, JA; Kobeissy, FH; Larner, SF; Wang, KK; Warren, MW | 1 |
| Boorman, M; Cairns, I; Chu, M; Drummer, OH; Gerostamoulos, D; Swann, P | 1 |
| Geier, JE; Gold, MS; Jeung, JA; Kobeissy, FH; Warren, MW | 1 |
| Gudelsky, GA; Herring, NR; Schaefer, TL; Skelton, MR; Vorhees, CV; Williams, MT | 1 |
| Ciullo, JR; De La Garza, R; Fantegrossi, WE; Traynor, JR; Wakabayashi, KT; Woods, JH | 1 |
| Andersson, M; Beck, O; Gustavsson, E; Stephanson, N | 1 |
| Huestis, MA; Kolbrich, EA; Lowe, RH | 1 |
| Kaneko, S; Nakagawa, T | 1 |
| Ashraf, T; Button, J; Dargan, PI; Drake, N; Greene, SL; Holt, DW; Ramsey, J; Walker, S; Wood, DM | 1 |
| Cheung, BK; Ho, AM; Leung, FY; Loxton, NJ; Stadlin, A; Tam, N; Wan, VL | 1 |
| Alizadeh, N; Mohammadi, A; Tabrizchi, M | 1 |
| Holmgren, A; Jones, AW; Kugelberg, FC | 1 |
| Kuwahara, T; Makie, T; Mori, M; Nakakura, T; Oda, S; Okamoto, G; Sasakawa, A; Takada, K; Uehira, T; Umemoto, A; Yajima, K; Yamamoto, Y; Yoshino, M | 1 |
| Baker, A; Kelly, E; Lee, N; Lubman, DI; Mattick, R; McKetin, R; Ross, J | 1 |
| Degenhardt, L; Kinner, SA | 1 |
| Hashimoto, K | 1 |
| Camarasa, J; Chipana, C; Escubedo, E; Pubill, D; Torres, I | 1 |
| Ishii, H; Nakagawa, Y; Ogata, A; Suzuki, T; Tayama, S | 1 |
| Cheong, JC; In, MK; Kim, JY; Kim, MK; Lee, JI | 1 |
| Halkitis, PN; Palamar, JJ | 1 |
| Maurer, HH; McCann, UD; Mueller, M; Peters, FT; Ricaurte, GA | 1 |
| Aasim, WR; Gan, SH; Tan, SC | 1 |
| Higuchi, M; Kaneko, S; Kitagawa, Y; Nagayasu, K; Nakagawa, T; Shirakawa, H; Suzuki, Y; Yatani, Y | 1 |
| Johansen, SS; Jornil, J | 1 |
| Sun, J; Wang, C; Xu, X; You, T | 1 |
| Albelda, MT; Costa, R; Domènech, A; Frías, JC; García-España, E; Navarro, P; Ortí, E; Reviriego, F; Yunta, MJ | 1 |
| Bafile, E; Compagnone, D; Curini, R; D'Ascenzo, G; Romolo, FS; Sergi, M | 1 |
| Bartzokis, G; Berman, S; Fears, S; London, ED; O'Neill, J | 1 |
| Barnes, AJ; Huestis, MA; Scheidweiler, KB | 1 |
| Dermatis, H; Franklin, J; Galanter, M; Horowitz, A | 1 |
| Cheong, JC; In, MK; Jin, C; Kim, JY; Ko, BJ; Lee, SK; Yoo, HH | 1 |
| Huestis, MA; Maurer, HH; Mueller, M; Peters, FT; Ricaurte, GA | 1 |
| Carbonaro, T; Forster, MJ; Gatch, MB; Rutledge, MA | 1 |
| Bauzo, RM; Fantegrossi, WE; Goodman, MM; Howell, LL; Manvich, DM; Morales, JC; Votaw, JR | 1 |
| Hasegawa, R; Ikeda, K; Karasawa, J; Tamura, K; Yamamoto, H; Yamamoto, T; Yasumoto, S | 1 |
| McGregor, IS; van Nieuwenhuijzen, PS | 1 |
| Green, KA; Halkitis, PN | 1 |
| Bhide, NS; Cunningham, JI; Gudelsky, GA; Lipton, JW; Yamamoto, BK | 1 |
| Banta-Green, CJ; Chiaia, AC; de Montigny, L; Field, JA; Power, L; Sudakin, DL | 1 |
| Maurer, HH; Meyer, MR; Schwaninger, AE; Zapp, J | 2 |
| Celikel, R; Owens, SM; Peterson, EC; Varughese, KI | 1 |
| Cerutti, DT; Galizio, M; McKinney, P; Pitts, RC | 1 |
| Iwamura, T; Okamura, N; Okuda, T; Sakurai, E; Shao, H; Takino, N; Yanai, K; Yoshikawa, T; Zhang, D | 1 |
| Gawlikowski, T; Gomółka, E; Król, A | 1 |
| Abraham, TT; Barnes, AJ; Goodwin, RS; Gorelick, DA; Huestis, MA; Kolbrich Spargo, EA; Lowe, RH; Milman, G; Pirnay, SO | 1 |
| Brennan, KA; Carati, C; Fitzmaurice, PS; Lea, RA; Schenk, S | 1 |
| Bruno, R; Degenhardt, L; Dunn, M; Gomez, R; Matthews, AJ; Topp, L | 1 |
| Camarasa, J; Chipana, C; Escubedo, E; García-Ratés, S; Pubill, D | 1 |
| Chen, YH; Chuang, CM; Huang, SS; Lin, PL; Lu, DY; Lu, GL; Tsai, MC; Yang, HY | 1 |
| Biezonski, DK; Meyer, JS | 1 |
| Ayala, ME | 1 |
| Kiyatkin, EA | 1 |
| In, MK; Kim, JY; Lee, JI; Shin, SH | 1 |
| Gunn, J; Kriger, S; Terrell, AR | 1 |
| Chen, GL; Lynch, LJ; Lynn, SK; Miller, GM; Panas, HN; Scanlan, TS; Vallender, EJ; Xie, Z | 1 |
| Bastos, ML; Branco, P; Carmo, H; Carvalho, F; da Silva, DG; de Pinho, PG; Ferreira, L; Pontes, H; Remião, F | 1 |
| Gudelsky, GA; Moszczynska, A; Yamamoto, BK | 1 |
| Chang, YP; Cheng, CP; Huang, YS; Yen, CF | 1 |
| Becker, J; Röhrich, J; Urban, R; Zörntlein, S | 1 |
| Blencowe, T; Gunnar, T; Impinen, A; Lillsunde, P; Pehrsson, A; Vimpari, K | 1 |
| Li, H; Metcalfe, C; Rodayan, A; Tindale, K; Yargeau, V | 1 |
| Chen, J; He, M; Hu, B; Xiong, J | 1 |
| Abrahamsson, J; Jonsson, U; Knudsen, K | 1 |
| Amos-Kroohs, R; Braun, AA; Grace, CE; Graham, DL; He, E; Schaefer, TL; Skelton, MR; Vorhees, CV; Williams, MT | 1 |
| Huang, YS; Lin, CH; Tang, TC; Yen, CF | 1 |
| Brunt, TM; Niesink, RJ; Poortman, A; van den Brink, W | 1 |
| Seger, D | 1 |
| Cassels, BK; Díaz-Véliz, G; Mora-Gutiérrez, S; Quinteros-Muñoz, D; Rebolledo-Fuentes, M; Sáez-Briones, P | 1 |
| Bedi, G; de Wit, H; Hyman, D | 1 |
| Choi, H; Chung, H; Chung, KH; In, S; Kim, J; Lee, S | 1 |
| Freissmuth, M; Montgomery, T; Sitte, HH; Steinkellner, T | 1 |
| Blacik, LJ; Kazarian, CM; Ntamack, AG; Romberg, RW; Snyder, JJ; Welsh, ER | 1 |
| Dijkhuizen, A; Lusthof, KJ; Maes, A; Oosting, R; Sprong, AG; Verschraagen, M | 1 |
| Heikman, PK; Ojanperä, IA; Rasanen, IJ | 1 |
| Bervoets, L; Blust, R; Covaci, A; Jorens, PG; Mougel, JF; Neels, H; Tarcomnicu, I; van Nuijs, AL | 1 |
| Ares-Santos, S; Colado, MI; Granado, N; Martin, ED; Moratalla, R; O'Shea, E; Oliva, I | 1 |
| Gibbs, A; King, R; Ogden, E; Owens, K; Parrott, AC; Scholey, AB; Stough, C; Swann, P | 1 |
| Inoue, H; Miyaguchi, H | 1 |
| Hung, HM; Tien, ND; Truong, NX | 1 |
| Beyer, J; Boorman, M; Drummer, OH; Gerostamoulos, D; Kourtis, I; Tayler, P | 1 |
| Chen, C; Felgate, PD; Irvine, RJ; Jaehne, EJ; Kostakis, C; White, JM | 1 |
| Carhart-Harris, RL; King, LA; Nutt, DJ | 1 |
| Chen, BH; Chen, PH; Lee, HH; Lee, JF; Lin, SY | 1 |
| Schilt, T; van Holst, RJ | 1 |
| Fuchigami, Y; Igari, Y; Ikeda, R; Kuroda, N; Nakashima, K; Wada, M | 1 |
| Goda, Y; Kawamura, M; Kikura-Hanajiri, R | 1 |
| Griffiths, R; Sweetsur, P; Wilkins, C | 1 |
| Largeron, M; Martinez, CM; McCann, U; Mechan, A; Mueller, M; Neudörffer, A; Ricaurte, GA | 1 |
| McIntire, SL; Schreiber, MA | 1 |
| Dickinson, G; Gilpin, NW; Price, JU; Taffe, MA; Vandewater, SA; Wright, MJ | 1 |
| Goiny, M; Ichinose, F; Kehr, J; Nyberg, F; Sievertsson, T; Yoshitake, S; Yoshitake, T | 1 |
| Huestis, MA; Maurer, HH; Meyer, MR; Schwaninger, AE | 1 |
| Foltin, RW; Gunderson, EW; Haney, M; Hart, CL; Kirkpatrick, MG; Perez, AY | 1 |
| Hondebrink, L; Meulenbelt, J; van den Berg, M; van Kleef, RG; Westerink, RH | 1 |
| Bruno, R; Carter, S; Eaglesham, G; Gartner, C; Hall, W; Kirkbride, P; Lai, FY; Mueller, JF; Ort, C; Prichard, J | 1 |
| Maurer, HH; Meyer, MR; Schwaninger, AE | 1 |
| Chen, C; Felgate, PD; Harpas, P; Irvine, RJ; Kostakis, C; White, JM | 1 |
| Bruno, R; Burns, L; Dunn, M; Roxburgh, A | 1 |
| Karila, L; Reynaud, M | 1 |
| Irvine, RJ; Majumder, I; White, JM | 1 |
| Fantegrossi, WE; Finton, BJ; Galloway, MP; Howell, LL; Murnane, KS; Perrine, SA | 1 |
| Hondebrink, L; Meijer, M; Meulenbelt, J; Rietjens, SJ; Westerink, RH | 1 |
| Brede, WR; Westin, AA | 1 |
| Downey, LA; King, R; Ogden, E; Papafotiou, K; Stough, C; Swann, P; Wesnes, K | 1 |
| Aaron, C; Freeman, S; Hedge, M; Leonard, K; Warrick, BJ; Wilson, J | 1 |
| Ayestas, MA; Baumann, MH; Brandt, SD; Cozzi, NV; Daley, PF; Partilla, JS; Rothman, RB; Ruoho, AE; Shulgin, AT; Sink, JR | 1 |
| Inoue, H; Iwata, YT; Kanamori, T; Kuwayama, K; Miyaguchi, H; Tsujikawa, K | 1 |
| Downey, LA; King, R; Ogden, E; Papafotiou, K; Stough, C; Swann, P | 1 |
| Kereszty, EM; Kovács, K; Tóth, AR | 1 |
| Baker, DR; Kasprzyk-Hordern, B | 1 |
| Choi, H; Chung, KH; In, S; Jang, CG; Kim, J; Lee, S; Oh, SM | 1 |
| Csák, R; Faragó, R; Rácz, J; Vadász, V | 1 |
| Brière, FN; Fallu, JS; Janosz, M; Pagani, LS | 1 |
| Ikeda, R; Kuroda, N; Nakashima, K; Nogami, K; Ochi, Y; Wada, M | 1 |
| Machalova, A; Slais, K; Sulcova, A; Vrskova, D | 1 |
| Bruno, R; Burns, L; Matthews, A; Roxburgh, A; Scott, LA | 1 |
| Aarde, SM; Angrish, D; Dickerson, TJ; Houseknecht, KL; Huang, PK; Taffe, MA | 1 |
| Baheri, T; Djozan, D; Farajzadeh, MA; Sorouraddin, SM | 1 |
| Kiyatkin, EA; Sharma, HS | 1 |
| Baker, DR; Kasprzyk-Hordern, B; Kvicalova, M; Očenášková, V | 1 |
| Flavel, SC; Todd, G; White, JM | 1 |
| Carmo, H; Dias da Silva, D; Silva, E | 1 |
| Fone, KC; Green, AR; King, MV; Shortall, SE; Swift, KM | 1 |
| Chen, C; Felgate, PD; Irvine, RJ; Kostakis, C; White, JM | 1 |
| Ebling, FJ; Fone, KC; Jayson, R; King, MV; Korsah, C; Macerola, AE; Pillidge, KE; Richard Green, A; Shortall, SE; Swaby, RT; Wigmore, PM | 1 |
| Carbonaro, TM; Forster, MJ; Gatch, MB | 1 |
| Hrubá, L; Macúchová, E; Nová, E; Pometlová, M; Rokyta, R; Schutová, B; Šlamberová, R | 1 |
| Šlamberová, R; Yamamotová, A | 1 |
| Angoa-Pérez, M; Briggs, DI; Francescutti, DM; Kane, MJ; Kuhn, DM; Shah, MM; Sykes, CE; Thomas, DM | 1 |
| Detels, R; Ding, Y; He, N | 1 |
| Kenichiro, N; Miki, K; Mitsuhiro, W; Naotaka, K; Rie, I; Yuki, F | 1 |
| Berg, D; Chatterton, B; Della Vedova, CB; Flavel, SC; Noyes, C; Spyropoulos, P; Todd, G; White, JM | 1 |
| Dargan, PI; Measham, F; Moore, K; Wood, DM | 1 |
| Burch, HJ; Clarke, EJ; Hubbard, AM; Scott-Ham, M | 1 |
| Fontana, AC; Kortagere, S; Mortensen, OV; Rose, DR | 1 |
| Clemons, K; Dziekonski, E; Fox, J; Verbeck, GF; Waverka, K; Wiley, R | 1 |
| Carmo, H; da Silva, DD; Silva, E | 1 |
| Bowman, B; Lasarow, A; Matzopoulos, R | 1 |
| Cockburn, AK; Livingstone, AC; Maskell, PD; Pounder, DJ; Preece, J; Seetohul, LN | 1 |
| Angoa-Pérez, M; Francescutti, DM; Herrera-Mundo, N; Kane, MJ; Kuhn, DM | 1 |
| Collins, SA; Halpin, LE; Yamamoto, BK | 1 |
| Bidel, Z; Carson, KV; Nazarzadeh, M | 1 |
| Baumann, MH; Concheiro, M; Huestis, MA; Marrone, GF; Rothman, RB; Scheidweiler, KB | 1 |
| Chalmers, J; Hughes, CE; Matthew-Simmons, F | 1 |
| Bruno, R; Carter, S; Lai, FY; Lam, PK; Leung, HW; Mueller, JF; Ort, C; Thai, PK; Thompson, K | 1 |
| Baumann, MH; Blough, BE; Goldberg, SR; Schindler, CW; Tella, SR; Thorndike, EB | 1 |
| Armstrong, K; Davey, J; Martin, P | 1 |
| Talbert, JJ | 1 |
| Downey, LA; Loftis, JM | 1 |
| Colado, MI; Green, AR; O'Shea, E; Urrutia, A | 1 |
| Fone, KC; Green, AR; King, MV; Shortall, SE | 2 |
| Bedi, G; Carrillo, F; Cecchi, GA; de Wit, H; Sigman, M; Slezak, DF | 1 |
| Antoni, MH; Durán, RE; Theodore, PS | 1 |
| Kirkbride, KP; Megharaj, M; Naidu, R; Pal, R | 1 |
| Berset, JD; Bijlsma, L; Castiglioni, S; Covaci, A; de Voogt, P; Emke, E; Fatta-Kassinos, D; González-Mariño, I; Grabic, R; Griffiths, P; Hernández, F; Kasprzyk-Hordern, B; Mastroianni, N; Meierjohann, A; Nefau, T; Ort, C; Ostman, M; Pico, Y; Racamonde, I; Reid, M; Slobodnik, J; Terzic, S; Thomaidis, N; Thomas, KV; van Nuijs, AL | 1 |
| Tacke, U; Uosukainen, H; Winstock, AR | 1 |
| Bruno, R; Burns, L; Butler, K; Dietze, P; Matthews, AJ | 1 |
| Harper, DN; Harrow, CC; Macaskill, AC | 1 |
| Kelly, JP; McDonnell-Dowling, K | 1 |
| Driver, CR; Hoffman, RS; Jakubowski, A; Karpati, A; Kass, D; Kunins, HV; Nelson, LS; Nolan, ML; Paone, D; Ridpath, A | 1 |
| Flavel, SC; Pearson-Dennett, V; Thewlis, D; Todd, G; Vogel, AP; White, JM; Wilcox, RA | 1 |
| Creehan, KM; Taffe, MA; Vandewater, SA | 2 |
| Hayashida, M; Ohno, Y; Uekusa, K | 1 |
| Hornykiewicz, O; Pifl, C; Reither, H | 1 |
| Aarde, SM; Creehan, KM; Miller, ML; Taffe, MA; Vandewater, SA | 1 |
| Forster, SL; Fulde, GW | 1 |
| Boels, D; Bretaudeau Deguigne, M; Bruneau, C; Harry, P; Le Roux, G; Lelièvre, B; Turcant, A | 1 |
| Chan, WL; Dargan, PI; Wood, DM | 1 |
| Costa, G; García-Montes, JR; Granado, N; Khairnar, A; Moratalla, R; Morelli, M; Porceddu, PF; Simola, N; Tizabi, Y | 1 |
| Baker, LE; Harvey, EL | 1 |
| Genzen, JR; Johnson-Davis, KL; Sadler, AJ | 1 |
| Kitaichi, K; Nawata, Y; Yamamoto, T | 1 |
| Drummer, OH; Forbes, SL; Fu, S; Luong, S; Philp, M; Stuart, BH; Wenholz, DS | 1 |
| Cleland, CM; Palamar, JJ; Salomone, A; Vincenti, M | 1 |
| Jawalkar, S; Parker, K; Prasad, J; Wilkins, C | 1 |
| Chu, M; Di Rago, M; Gerostamoulos, D; Jenkins, E; Kotsos, A; Rodda, LN | 1 |
| Bruno, R; Holland, BR; Humphries, MA; Lai, FY; Mueller, JF; O'Brien, JW; Ort, C; Thai, PK | 1 |
| Dolan, SB; Forster, MJ; Gatch, MB | 3 |
| Hrebíčková, I; Macúchová, E; Nohejlová, K; Ševčíková, M; Šlamberová, R | 2 |
| Argente-García, A; Campíns-Falcó, P; Herráez-Hernández, R; Moliner-Martínez, Y; Verdú-Andrés, J | 1 |
| Bagnall, J; Evans, SE; Kasprzyk-Hordern, B | 1 |
| de la Torre, R; Farré, M; Fonseca, F; Mateus, JA; Olesti, E; Papaseit, E; Pérez-Mañá, C; Pujadas, M; Torrens, M | 1 |
| Henion, J; Verplaetse, R | 1 |
| Burns, L; Degenhardt, L; Dobbins, T; Farrell, M; Hall, WD; McKetin, R; Roxburgh, A; Sara, G | 1 |
| Ali, SF; Cuevas, E; Fantegrossi, WE; Gannon, BM; Gonzalez, C; Lantz, SM; Paule, MG; Rice, KC; Rosas-Hernandez, H | 1 |
| Anuj, S; Bruno, R; Carter, S; Chan, G; Gartner, C; Hall, W; Humphries, M; Kirkbride, KP; Lai, FY; Mueller, JF; O'Brien, JW; Ort, C; Prichard, J; Thai, PK | 1 |
| Jones, L; Parrott, A; Reed, P | 1 |
| Olive, MF; Watterson, LR | 1 |
| Bodík, I; Fáberová, M; Ivanová, L; Mackuľak, T | 1 |
| de la Torre, R; de Sousa Fernandes Perna, EB; Farré, M; Kuypers, K; Mateus, J; Papaseit, E; Pérez-Mañá, C; Ramaekers, JG; Theunissen, EL | 1 |
| Cameron, S; Collins, M; Donnelly, C; Salouros, H; Tahtouh, M | 1 |
| Kiyatkin, EA; Ren, SE | 1 |
| Castiglioni, S; Gracia-Lor, E; Zuccato, E | 1 |
| Banks, ML; Negus, SS | 1 |
| Bade, R; Baz-Lomba, JA; Bramness, J; Castiglioni, S; Castrignanò, E; Causanilles, A; de Voogt, P; Gracia-Lor, E; Hernandez, F; Kasprzyk-Hordern, B; Kinyua, J; McCall, AK; Ort, C; Plósz, BG; Ramin, P; Reid, M; Rousis, NI; Ryu, Y; Salvatore, S; Thomas, K; van Nuijs, A | 1 |
| Aarde, SM; Taffe, MA | 1 |
| Biała, G; Budzynska, B; Frankowska, M; Kaszubska, K; Michalak, A | 1 |
| Cherney, A; Kemp, R; Legosz, M; Leslie, EM; Najman, JM; Smirnov, A; Wells, H | 1 |
| Janowsky, A; Miner, NB; O'Callaghan, JP; Phillips, TJ | 1 |
| Di Corcia, D; Gerace, E; Palamar, JJ; Salomone, A; Vincenti, M | 1 |
| Chandler, EB; Howell, LL; Kohn, JN; Logun, MT; Minerva, AR; Pitts, EG; Rice, KC; Sulima, A | 1 |
| Castiglioni, S; Gracia-Lor, E; Parabiaghi, A; Riva, F; Rousis, NI; Senta, I; Zuccato, E | 1 |
| Dong, R; Huang, L; Liang, D; Weng, S; Zhang, D; Zhao, J; Zhu, Z | 1 |
| Griffiths, A; Hadley, L; Leonars, R; Stephenson, M; Teale, R | 1 |
| Kahler-Venter, CP; Mothibe, ME; Osuch, E | 1 |
| Gonçalves, ILP; Kuca, K; Nepovimova, E; Neto, AFG; Neto, AMJC; Reis, AFVF; Santos, AS | 1 |
| Archer, E; Castrignanò, E; Kasprzyk-Hordern, B; Wolfaardt, GM | 1 |
| Chen, Z; Dolan, SB; Gatch, MB; Huang, R | 1 |
| Desai, M; Edmundson, C; Glass, R; Heinsbroek, E; Hope, V | 1 |
| Bade, R; Cooke, R; Gerber, C; Longo, M; Tscharke, BJ; White, JM | 1 |
| He, L; Jiang, J; Li, X; Luo, Y; Pan, X; Wang, N; Yang, J; Zhang, X | 1 |
| Blanckaert, P; Coopman, V; Cordonnier, J; Risseeuw, MDP; Van Calenbergh, S; Vanquekelberghe, S | 1 |
| Aryal, R; Gerber, C; Saint, CP; Short, MD; van den Akker, B; Yadav, MK | 1 |
| Lai, FY; Mueller, JF; O'Brien, J; Thai, P; Wilkins, C | 1 |
| Baranyi, M; Hegyi, DE; Vizi, ES; Zsilla, G | 1 |
| Addison, M; Gilvarry, E; Kaner, E; Martens, MS; McGovern, R; O'Donnell, A; Rosenkranz, M; Spencer, L; Verthein, U; Zurhold, H | 1 |
| Keehbauch, JT; Klega, AE | 1 |
| Graydon-Guy, T; Prasad, J; Romeo, JS; Rychert, M; Wilkins, C | 1 |
| Brunt, TM; Carbó, ML; de la Torre, R; De Toma, I; Dierssen, M; Farré, M; Fernández-Avilés, C; Olesti, E; Pozo, ÓJ; Ramaekers, JG; Robledo, P | 1 |
| Beck, A; Flockerzi, V; Maurer, HH; Meyer, MR; Richter, LHJ | 1 |
| Chen, MY; Chen, YS; Chong, MY; Chou, WJ; Lin, CY; Lu, SF; Tsai, CP; Wang, LJ; You, YH | 1 |
| Gordon, AJ; Metz, TD; Smid, MC | 1 |
| Baumann, MH; Blough, BE; Hoener, MC; Kolaczynska, KE; Liechti, ME; Luethi, D; Rice, KC; Suzuki, M; Walter, M | 1 |
| Bershad, AK; de Wit, H; Mayo, LM; McGlone, F; Van Hedger, K; Walker, SC | 1 |
| Bernardo, RA; Chaves, AR; da Silva, LC; Queiroz, MEC; Vaz, BG | 1 |
| Baker, LE; Berquist, MD; Bullock, TA | 1 |
| Lappin, JM; Sara, GE | 1 |
| Bourgogne, E; Delhotal-Landes, B; Gourlain, H; Labat, L; Leclercq, M; Mégarbane, B; Soichot, M | 1 |
| Mesihää, S; Ojanperä, I; Pelander, A; Rasanen, I | 1 |
| Burns, L; Esterman, A; Faulkner, PL; Pearson-Dennett, V; Thewlis, D; Todd, G; Vogel, AP; White, JM; Wilcox, RA | 1 |
| Amundsen, EJ; Baz-Lomba, JA; de Voogt, P; Emke, E; Goulding, N; Hall, W; Hickman, M; Jones, HE; Kuijpers, W; O'Brien, JW; Reid, M; Tscharke, BJ | 1 |
| Alygizakis, NA; Andrés-Costa, MJ; Bade, R; Bannwarth, A; Barron, LP; Baz-Lomba, JA; Been, F; Benaglia, L; Berset, JD; Bijlsma, L; Bodík, I; Brenner, A; Brock, AL; Burgard, DA; Castiglioni, S; Castrignanò, E; Celma, A; Christophoridis, CE; Covaci, A; de Voogt, P; Delémont, O; Devault, DA; Dias, MJ; Emke, E; Esseiva, P; Fatta-Kassinos, D; Fedorova, G; Fytianos, K; Gerber, C; González-Mariño, I; Grabic, R; Gracia-Lor, E; Grüner, S; Gunnar, T; Hapeshi, E; Heath, E; Helm, B; Hernández, F; Kankaanpaa, A; Karolak, S; Kasprzyk-Hordern, B; Krizman-Matasic, I; Lai, FY; Lechowicz, W; Lopes, A; López de Alda, M; López-García, E; Löve, ASC; Mastroianni, N; McEneff, GL; Montes, R; Munro, K; Nefau, T; O'Brien, JW; Oberacher, H; Oertel, R; Olafsdottir, K; Ort, C; Picó, Y; Plósz, BG; Polesel, F; Postigo, C; Quintana, JB; Ramin, P; Reid, MJ; Rice, J; Rodil, R; Salgueiro-González, N; Schubert, S; Senta, I; Simões, SM; Sremacki, MM; Styszko, K; Terzic, S; Thomaidis, NS; Thomas, KV; Tscharke, BJ; Udrisard, R; van Nuijs, ALN; Yargeau, V; Zuccato, E | 1 |
| Chiu, YC; Lin, C; Lin, YH; Lo, MT; Wong, BY | 1 |
| Gore, S; Huber, R; Sprague, JE; van Staaden, MJ | 1 |
| Burgueño, MJ; Castro, MÁ; Mateos-Campos, R; Sánchez, S | 1 |
| Miner, NB; Mootz, JRK; Phillips, TJ | 1 |
| Cui, J; Liu, W; Shen, B; Shen, M; Wang, X; Xiang, P; Zhang, S; Zhuo, Y | 1 |
| Busardò, FP; Gottardi, M; Graziano, S; Malaca, S; Marchei, E; Pichini, S | 1 |
| Hall, FS; Issa, O; Muskiewicz, DE; Resendiz-Gutierrez, F | 1 |
| Mead, J; Parrott, A | 1 |
| Chen, Y; Hall, FS; Saber, YH; Tran, HTN | 1 |
| Derlet, RW; Laurin, EG; Placone, TW; Richards, JR; van der Linden, MC; Wang, CG | 1 |
| Hirayama, S; Hokazono, M; Iwase, Y; Masukawa, D; Mori, T; Suzuki, T; Udagawa, Y; Uzawa, N | 1 |
| Fan, Y; Huang, Z; Liu, H; Liu, Y; Shen, Z; Wang, L; Watanabe, I | 1 |
| Palamar, JJ; Salomone, A | 1 |
| Daviskiba, S; Dean, D; Kern, P; King, A; Reed, B; Rockhill, S; Vohra, V | 1 |
| Bergman, J; de Moura, FB; Kohut, SJ; Paronis, CA; Prisinzano, TE; Sherwood, A | 1 |
| Bergman, J; Kohut, SJ; Paronis, CA; Prisinzano, TE; Sherwood, AM; Wakeford, AGP | 1 |
| Christoffel, DJ; Deisseroth, K; Heifets, BD; Hoerbelt, P; Llorach, P; Lopez, RC; Malenka, RC; Ramakrishnan, C; Walsh, JJ | 1 |
| Hess, C; Losacker, M; Röhrich, J; Schwarze, B; Staudt, S; Zörntlein, S | 1 |
| Baker, T; Mueller, JF; Price, M; Trowsdale, S; Tscharke, BJ; Wilkins, C | 1 |
| Davey, CG | 1 |
| Hudson, M; McDonnell, JM; Pollard, C; Royall, PG; Wolff, K | 1 |
| De Luca, MA; Simola, N | 1 |
| Alexeev, S; Livingston, M; Weatherburn, D | 1 |
| Cleland, CM; Keyes, KM; Palamar, JJ; Rutherford, C | 1 |
| Casey, LE; Kemp, R; Pourmarzi, D; Smirnov, A; Wessel, EL | 1 |
| Mellos, E; Paparrigopoulos, T | 1 |
| Ducret, P; Hoener, MC; Kolaczynska, KE; Liechti, ME; Luethi, D; Trachsel, D | 1 |
| Chen, LY; Chen, MH; Chen, YH; Wei, HT | 1 |
| Heath, D; Heath, E; Verovšek, T | 1 |
| Bijlsma, L; Capela, R; Cela, R; Celma, A; Estévez-Danta, A; Hernández, F; Lertxundi, U; Matias, J; Montes, R; Orive, G; Prieto, A; Quintana, JB; Rodil, R; Santos, MM | 1 |
| Bruno, R; Chrzanowska, A; Degenhardt, L; Dietze, PM; Gibbs, D; Man, N; McKetin, R; Peacock, A; Price, O; Salom, C; Sisson, SA | 1 |
| Coulter, C; Garnier, M; Moore, C | 1 |
| Du, H; Fu, D; Lai, M; Liu, H; Wang, Y; Xu, P; Xu, Z; Zhou, W | 1 |
| Armstrong, B; Chappell, A; Grigg, S; Jay, E; McCormick, S; Phung, K; Waite, B | 1 |
| Hosseini, A; Shetab-Boushehri, SM; Shetab-Boushehri, SV | 1 |
| Guzel, EY | 1 |
| Hill, VA; Paulsen, RB; Schaffer, MI; Stowe, GN | 1 |
| An, Q; Bai, D; Huo, T; Li, X; Wang, H; Xu, B; Yang, L | 1 |
| Dong, H; Li, W; Lu, J; Yan, Y; Zhao, H; Zhao, J | 1 |
| Fatta-Kassinos, D; Michael, C; Mina, C; Mina, T; Psichoudaki, M; Savvidou, M | 1 |
| Béen, F; Benschop, A; Emke, E; Nabben, T; Ter Laak, TL | 1 |
| Haug, NA; Macia, KS; Sottile, JE; Wickham, RE | 1 |
| Bailey, JM; Bowman, SK; Cerveny, SE; Huang, S; Jones, RA; Manke, HN; Nelson, KH; Rice, KC; Riley, AL | 1 |
| McGrane, IR; Omar, FA; Ramsbacher, NC; Rook, WC | 1 |
| Ayerdi, O; Belza, MJ; de la Fuente, L; Donat, M; García de Olalla, P; García-Pérez, JN; Guerras, JM; Hoyos, J; Palma Díaz, D | 1 |
| Chen, H; Di, B; Hu, J; Ji, J; Li, B; Liu, M; Liu, W | 1 |
| Bola, RA; Cameron-Burr, KT; Kiyatkin, EA | 1 |
| Agramunt, S; Bruno, R; Degenhardt, L; Dietze, P; Grigg, J; Man, N; Peacock, A; Price, O; Salom, C; Sutherland, R | 1 |
| Haghparast, A; Karimi-Haghighi, S; Mahmoudi, M; Mozafari, R; Sayehmiri, F | 1 |
| Bahrke, J; Hopkins, A; Kessler, L; Kunstman, K | 1 |
| Palamar, JJ | 1 |
| Cruz, SL; Paz-Ramos, MI; Violante-Soria, V | 1 |
| de Wit, H; Lee, R; Lyubomirsky, S; Molla, H | 1 |
| Guo, S; Hui, T | 1 |
| Birkett, M; Janulis, P; Jenness, SM; Mustanski, B; Phillips, G; Risher, K | 1 |
| Beradinelli, D; Berretta, P; Busardò, FP; Chankvetadze, B; Di Giorgi, A; Farkas, T; Farre, M; Lo Faro, AF; Papaseit, E; Poyatos, L; Sprega, G; Takaishvili, N; Tini, A | 1 |
| Choe, S; Kang, S; Kim, J; Lee, N; Park, M; Park, Y; Song, J; Yum, H | 1 |
41 review(s) available for methamphetamine and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Examination of developmental neurotoxicity by the use of tissue culture model systems.
Topics: Appetite Depressants; Cell Line; Central Nervous System Stimulants; Culture Techniques; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Embryonic and Fetal Development; Fenfluramine; Humans; Illicit Drugs; Mesencephalon; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxins; Serotonin; Serotonin Agents; Tumor Cells, Cultured | 1995 |
Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction.
Topics: Animals; Central Nervous System Stimulants; Hallucinogens; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Rats | 1996 |
Free radicals and the pathobiology of brain dopamine systems.
Topics: Animals; Brain; Dopamine; Free Radicals; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurodegenerative Diseases; Oxidopamine; Parkinson Disease; Reactive Oxygen Species | 1998 |
The effects and consequences of selected club drugs.
Topics: Central Nervous System Stimulants; Humans; Ketamine; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Sodium Oxybate; Substance-Related Disorders | 2002 |
Club drugs: is it all ecstasy?
Topics: Adolescent; Adolescent Behavior; Anxiety Disorders; Humans; Illicit Drugs; Ketamine; Methamphetamine; Muscle Cramp; N-Methyl-3,4-methylenedioxyamphetamine; Risk-Taking; Sodium Oxybate; Substance-Related Disorders | 2002 |
[Stimulant dependence].
Topics: Amphetamine-Related Disorders; Antipsychotic Agents; Central Nervous System Stimulants; Humans; Methamphetamine; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Self-Help Groups; Social Support | 2003 |
Rave drugs: pharmacological considerations.
Topics: Adolescent; Adult; Anesthesia; Dancing; Designer Drugs; Emergency Treatment; Flunitrazepam; Hallucinogens; Humans; Hydroxybutyrates; Illicit Drugs; Ketamine; Lysergic Acid Diethylamide; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Substance-Related Disorders | 2004 |
Common drugs of abuse--Part II.
Topics: 4-Butyrolactone; Catha; Designer Drugs; Dibenzothiazepines; Diterpenes; Diterpenes, Clerodane; DOM 2,5-Dimethoxy-4-Methylamphetamine; Drug and Narcotic Control; Flunitrazepam; Hallucinogens; Humans; Illicit Drugs; Ketamine; Lysergic Acid Diethylamide; Methamphetamine; Motivation; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Phenylpropanolamine; Piperazines; Psilocybin; Quetiapine Fumarate; Sodium Oxybate; Substance-Related Disorders; United States | 2004 |
Methamphetamine and MDMA (ecstasy) neurotoxicity: 'of mice and men'.
Topics: Animals; Brain; Humans; Methamphetamine; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Psychotropic Drugs | 2004 |
Club drugs and HIV infection: a review.
Topics: Adolescent; Adult; Drug Prescriptions; HIV Infections; Homosexuality, Male; Humans; Illicit Drugs; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Risk-Taking; United States | 2006 |
Ecstasy (MDMA), methamphetamine, and date rape (drug-facilitated sexual assault): a consideration of the issues.
Topics: Coma; Female; Humans; Illicit Drugs; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rape; Sex Offenses | 2006 |
Causes and consequences of methamphetamine and MDMA toxicity.
Topics: Blood-Brain Barrier; Dopamine; Humans; Methamphetamine; Mitochondria; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxins; Oxidative Stress; Substance-Related Disorders; United States | 2006 |
MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Brain; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Interactions; Hallucinogens; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Social Behavior; Substance Abuse, Intravenous; Substance-Related Disorders | 2007 |
Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms.
Topics: Amphetamines; Animals; Apoptosis; Central Nervous System Stimulants; Dopamine; Fever; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Oxidative Stress | 2007 |
Neuropsychotoxicity of abused drugs: molecular and neural mechanisms of neuropsychotoxicity induced by methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and 5-methoxy-N,N-diisopropyltryptamine (foxy).
Topics: 5-Methoxytryptamine; Animals; Brain; Central Nervous System Stimulants; Dopamine; Dopamine Plasma Membrane Transport Proteins; Glutamine; Humans; Limbic System; Membrane Potentials; Mesencephalon; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Neurotoxicity Syndromes; Oocytes; Organ Culture Techniques; Raphe Nuclei; Serotonin; Serotonin Plasma Membrane Transport Proteins; Substance-Related Disorders; Xenopus | 2008 |
[Minocycline as a therapeutic drug for methamphetamine use disorders].
Topics: Animals; Anti-Bacterial Agents; Brain; Disease Models, Animal; Humans; Methamphetamine; Minocycline; N-Methyl-3,4-methylenedioxyamphetamine; Positron-Emission Tomography; Psychoses, Substance-Induced; Schizophrenia; Substance-Related Disorders | 2008 |
Abuse of amphetamines and structural abnormalities in the brain.
Topics: Abnormalities, Drug-Induced; Adult; Amphetamine-Related Disorders; Amphetamines; Animals; Attention Deficit Disorder with Hyperactivity; Brain; Cats; Female; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Myelin Sheath; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Neurotransmitter Agents; Pregnancy; Prenatal Exposure Delayed Effects; Primates; Rats; Species Specificity | 2008 |
Involvement of nicotinic receptors in methamphetamine- and MDMA-induced neurotoxicity: pharmacological implications.
Topics: Animals; Brain; Central Nervous System Stimulants; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Reactive Oxygen Species; Receptors, Nicotinic | 2009 |
Amphetamine toxicities: classical and emerging mechanisms.
Topics: Amphetamines; Animals; Blood-Brain Barrier; Brain; Central Nervous System Stimulants; HIV Infections; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Oxidative Stress; Stress, Physiological; Substance-Related Disorders | 2010 |
Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.
Topics: Adaptation, Physiological; Brain; Central Nervous System Stimulants; Cocaine; Dopamine; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Oxidative Stress; Receptors, Dopamine D2; Serotonin; Serotonin Plasma Membrane Transport Proteins; Substance-Related Disorders; Synaptic Transmission; Vesicular Monoamine Transport Proteins | 2010 |
The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine.
Topics: Amphetamines; Animals; Dextroamphetamine; Humans; Methamphetamine; Mitochondria; Molecular Structure; N-Methyl-3,4-methylenedioxyamphetamine; Psychoses, Substance-Induced; Substance-Related Disorders; Time Factors | 2011 |
Drug-related decrease in neuropsychological functions of abstinent drug users.
Topics: Alcoholism; Amphetamine-Related Disorders; Cannabis; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Drug Users; Hallucinogens; Heroin Dependence; Humans; Marijuana Abuse; Memory Disorders; Methadone; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Opioid-Related Disorders; Psychomotor Performance; Recognition, Psychology; Substance-Related Disorders; Verbal Behavior | 2011 |
GHB and synthetic cathinones: clinical effects and potential consequences.
Topics: Alkaloids; Animals; Designer Drugs; Humans; Illicit Drugs; Indans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Sodium Oxybate; Substance-Related Disorders | 2011 |
Environmental conditions modulate neurotoxic effects of psychomotor stimulant drugs of abuse.
Topics: Animals; Blood-Brain Barrier; Body Temperature; Brain; Brain Edema; Environment; Fever; Hot Temperature; Illicit Drugs; Interpersonal Relations; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Degeneration; Neuroglia | 2012 |
Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine.
Topics: Animals; Central Nervous System Stimulants; Dopamine; Hallucinogens; Humans; Methamphetamine; Mitochondria; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Endings; Neurotoxicity Syndromes; Oxidative Stress; Serotonin | 2014 |
Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine.
Topics: Amphetamine-Related Disorders; Animals; Brain; Central Nervous System Stimulants; Energy Metabolism; Humans; Inflammation Mediators; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Oxidative Stress; Recurrence; Substance Withdrawal Syndrome | 2014 |
Current preclinical studies on neuroinflammation and changes in blood-brain barrier integrity by MDMA and methamphetamine.
Topics: Animals; Blood-Brain Barrier; Brain; Capillary Permeability; Central Nervous System Stimulants; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neuroimmunomodulation | 2014 |
The preclinical pharmacology of mephedrone; not just MDMA by another name.
Topics: Animals; Biogenic Monoamines; Brain; Drug Evaluation, Preclinical; Humans; Illicit Drugs; Methamphetamine; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats | 2014 |
Sources of variation in the design of preclinical studies assessing the effects of amphetamine-type stimulants in pregnancy and lactation.
Topics: Amphetamine; Amphetamines; Animals; Animals, Newborn; Central Nervous System Stimulants; Disease Models, Animal; Female; Lactation; Methamphetamine; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Rats, Wistar; Research Design | 2015 |
The impact of amphetamine-type stimulants on emergency services.
Topics: Acute Disease; Aggression; Amphetamine; Amphetamine-Related Disorders; Anxiety; Central Nervous System Stimulants; Delusions; Depression; Drug Overdose; Emergency Service, Hospital; Hallucinations; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Paranoid Disorders; Sleep Initiation and Maintenance Disorders; Suicidal Ideation | 2015 |
Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms.
Topics: Animals; Brain; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes | 2017 |
Reinforcing Effects of Cathinone NPS in the Intravenous Drug Self-Administration Paradigm.
Topics: Administration, Intravenous; Alkaloids; Animals; Behavior, Animal; Benzodioxoles; Central Nervous System Stimulants; Cocaine; Conditioning, Operant; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Psychotropic Drugs; Pyrrolidines; Rats; Reinforcement, Psychology; Self Administration; Synthetic Cathinone | 2017 |
Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration.
Topics: Animals; Behavior, Animal; Methamphetamine; Models, Animal; N-Methyl-3,4-methylenedioxyamphetamine; Psychotropic Drugs; Rats; Self Administration; Substance-Related Disorders | 2017 |
Which individual, social and environmental influences shape key phases in the amphetamine type stimulant use trajectory? A systematic narrative review and thematic synthesis of the qualitative literature.
Topics: Amphetamine-Related Disorders; Disease Progression; Humans; Methamphetamine; Motivation; N-Methyl-3,4-methylenedioxyamphetamine; Peer Group; Qualitative Research; Risk Factors; Sexual Behavior; Social Behavior; Social Environment | 2019 |
Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women.
Topics: Alkaloids; Central Nervous System Stimulants; Cocaine; Female; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pregnancy; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Substance-Related Disorders; Systematic Reviews as Topic; United States | 2019 |
Psychostimulant use and the brain.
Topics: Amphetamine; Amphetamine-Related Disorders; Brain; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Cognitive Dysfunction; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Seizures; Stroke | 2019 |
Mephedrone and MDMA: A comparative review.
Topics: Brain; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes | 2020 |
Substance use during the COVID-19 pandemic: What is really happening?
Topics: Adult; Benzodiazepines; Cocaine; Communicable Disease Control; COVID-19; Cross-Sectional Studies; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Pandemics; Retrospective Studies; SARS-CoV-2; Substance-Related Disorders; Wastewater | 2022 |
Effects of 3,4-methylenedioxymethamphetamine and methamphetamine on motor vehicle driving performance: A systematic review of experimental and observational studies.
Topics: Humans; Methamphetamine; Motor Vehicles; N-Methyl-3,4-methylenedioxyamphetamine | 2023 |
Endocannabinoid system as a therapeutic target for psychostimulants relapse: A systematic review of preclinical studies.
Topics: Amphetamine; Animals; Cannabinoid Receptor Antagonists; Central Nervous System Stimulants; Cocaine; Endocannabinoids; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Receptors, Cannabinoid; Recurrence | 2023 |
Amphetamine-type Stimulants: Novel Insights into their Actions and use Patterns.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Central Nervous System Stimulants; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine | 2023 |
10 trial(s) available for methamphetamine and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS.
Topics: 3,4-Methylenedioxyamphetamine; Administration, Oral; Adolescent; Adult; Chromatography, High Pressure Liquid; Deoxyepinephrine; Female; Fluorocarbons; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Hydrolysis; Ion Exchange Resins; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reference Standards | 1996 |
Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Area Under Curve; Blood Pressure; Cross-Over Studies; Deoxyepinephrine; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Hallucinogens; Humans; Hydrogen-Ion Concentration; Male; Metabolic Clearance Rate; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pilot Projects; Time Factors | 2000 |
Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis.
Topics: 3,4-Methylenedioxyamphetamine; Deoxyepinephrine; Electrophoresis, Capillary; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism; Substance Abuse Detection | 2002 |
Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others.
Topics: Adolescent; Adult; Affect; Empathy; Facial Expression; Female; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Photic Stimulation; Psychomotor Performance; Self Report | 2010 |
MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study.
Topics: Administration, Oral; Adult; Affect; Automobile Driving; Central Nervous System Stimulants; Double-Blind Method; Female; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Time Factors; Young Adult | 2011 |
The acute effects of 3,4-methylenedioxymethamphetamine and d-methamphetamine on human cognitive functioning.
Topics: Adult; Cognition; Double-Blind Method; Female; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Photic Stimulation; Psychomotor Performance; Reaction Time; Time Factors; Young Adult | 2012 |
The acute effects of 3,4-methylenedioxymethamphetamine and methamphetamine on driving: a simulator study.
Topics: Acceleration; Adrenergic Uptake Inhibitors; Adult; Attention; Automobile Driving; Central Nervous System Stimulants; Computer Simulation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Illicit Drugs; Judgment; Male; Metabolic Clearance Rate; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Psychomotor Performance; Safety; Young Adult | 2012 |
A window into the intoxicated mind? Speech as an index of psychoactive drug effects.
Topics: Adolescent; Adult; Artificial Intelligence; Double-Blind Method; Female; Humans; Illicit Drugs; Male; Mental Processes; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pattern Recognition, Automated; Psychotropic Drugs; Semantics; Speech; Substance-Related Disorders; Young Adult | 2014 |
Human Pharmacology of Mephedrone in Comparison with MDMA.
Topics: Adult; Blood Pressure; Body Temperature; Central Nervous System Stimulants; Cross-Over Studies; Double-Blind Method; Hallucinogens; Healthy Volunteers; Heart Rate; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Psychomotor Performance; Pupil; Time Factors; Visual Analog Scale; Young Adult | 2016 |
Effects of MDMA on attention to positive social cues and pleasantness of affective touch.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Affect; Attention; Attentional Bias; Cues; Double-Blind Method; Electromyography; Electrooculography; Facial Muscles; Female; Healthy Volunteers; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pleasure; Social Behavior; Touch Perception; Young Adult | 2019 |
399 other study(ies) available for methamphetamine and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Trace amine-associated receptor 1 is a stereoselective binding site for compounds in the amphetamine class.
Topics: Amphetamines; Animals; Binding Sites; Cell Line; Humans; Macaca mulatta; Mice; Rats; Receptors, G-Protein-Coupled; Transfection | 2011 |
The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.
Topics: Animals; Central Nervous System Stimulants; Chemistry, Pharmaceutical; Dopamine; Drug Discovery; Hallucinogens; Humans; Illicit Drugs; Norepinephrine; Phenethylamines; Psychotropic Drugs; Receptors, Serotonin; Serotonin | 2017 |
Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain; Chromatography, High Pressure Liquid; Dopamine; Injections, Intraventricular; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Serotonin; Tryptophan Hydroxylase | 1992 |
Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; Analysis of Variance; Animals; Aspartic Acid; Corpus Striatum; Designer Drugs; Dialysis; Dopamine; Glutamates; Kinetics; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxins; Rats; Rats, Wistar; Reference Values; Taurine; Time Factors | 1992 |
The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Calcium; Cocaine; Fenfluramine; Fluoxetine; In Vitro Techniques; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine; Potassium Chloride; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Synaptosomes | 1992 |
Investigation of MDMA-related agents in rats trained to discriminate MDMA from saline.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Discrimination, Psychological; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley | 1992 |
The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Corpus Striatum; Dizocilpine Maleate; Hippocampus; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; N-Methylaspartate; p-Chloroamphetamine; Rats; Serotonin | 1992 |
Comparative investigation of disposition of 3,4-(methylenedioxy)methamphetamine (MDMA) in the rat and the mouse by a capillary gas chromatography-mass spectrometry assay based on perfluorotributylamine-enhanced ammonia positive ion chemical ionization.
Topics: 3,4-Methylenedioxyamphetamine; Ammonia; Animals; Dopamine; Fluorocarbons; Gas Chromatography-Mass Spectrometry; Male; Methamphetamine; Mice; Mice, Inbred Strains; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Species Specificity | 1992 |
Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain; Chromatography, High Pressure Liquid; Diltiazem; Drug Interactions; Enzyme Induction; Flunarizine; Hydroxyindoleacetic Acid; Injections, Subcutaneous; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nimodipine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Serotonin; Tryptophan Hydroxylase | 1992 |
Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Brain Chemistry; Hallucinogens; Hydroxyindoleacetic Acid; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Rats; Rats, Sprague-Dawley; Serotonin; Structure-Activity Relationship | 1992 |
L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Chemistry; Cerebral Cortex; Corpus Striatum; Dopamine; Drug Synergism; Fenfluramine; Hippocampus; Levodopa; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Degeneration; Nerve Endings; Nervous System Diseases; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Serotonin | 1991 |
Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine and methylenedioxyamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Dose-Response Relationship, Drug; Drinking Behavior; Drug Tolerance; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains | 1990 |
Neurochemical basis of neurotoxicity.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Biogenic Monoamines; Designer Drugs; Dopamine; Glutamates; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System; Nervous System Diseases; Serotonin | 1990 |
The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Brain; Hydroxyindoleacetic Acid; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Serotonin; Tryptophan Hydroxylase | 1987 |
Effects of amphetamine analogs on central nervous system neuropeptide systems.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Brain Chemistry; Dynorphins; Extrapyramidal Tracts; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neuropeptides; Neurotensin; Rats; Rats, Inbred Strains; Substance P | 1989 |
Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Anticonvulsants; Dibenzocycloheptenes; Dizocilpine Maleate; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Tryptophan Hydroxylase | 1989 |
MK-801 attenuates the methamphetamine induced decreased in tryptophan hydroxylase activity.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Anticonvulsants; Brain; Corpus Striatum; Dibenzocycloheptenes; Dizocilpine Maleate; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Degeneration; Rats; Rats, Inbred Strains; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Receptors, Serotonin; Tryptophan Hydroxylase | 1989 |
Spectral and inhibitory interactions of (+/-)-3,4-methylenedioxyamphetamine (MDA) and (+/-)-3,4-methylenedioxymethamphetamine (MDMA) with rat hepatic microsomes.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Benzphetamine; Cytochrome P-450 Enzyme System; Kinetics; Male; Methamphetamine; Methimazole; Microsomes, Liver; N-Methyl-3,4-methylenedioxyamphetamine; NADP; Oxidoreductases, N-Demethylating; Rats; Spectrophotometry | 1986 |
MDMA and MDA cross reactivity observed with Abbott TDx amphetamine/methamphetamine reagents.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamine; Amphetamines; Cross Reactions; Female; Fluorescence Polarization; Gas Chromatography-Mass Spectrometry; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reagent Kits, Diagnostic | 1988 |
Characterization of methamphetamine effects on the striatal-nigral dynorphin system.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Corpus Striatum; Dynorphins; Hydroxydopamines; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Oxidopamine; Radioimmunoassay; Rats; Rats, Inbred Strains; Substantia Nigra; Sympathectomy, Chemical | 1988 |
Simultaneous determination of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in human hair by gas chromatography-mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Gas Chromatography-Mass Spectrometry; Hair; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Substance-Related Disorders | 1995 |
Involvement of oxidative and L-arginine-NO pathways in the neurotoxicity of drugs of abuse in vitro.
Topics: Adenosine Diphosphate Ribose; Animals; Arginine; Brain; Cell Death; Cells, Cultured; Dopamine; Dopamine Agents; Female; Free Radicals; Gene Expression Regulation; Gliosis; Illicit Drugs; Methamphetamine; Mice; Mice, Transgenic; N-Methyl-3,4-methylenedioxyamphetamine; Nitric Oxide; Oxidative Stress; Pregnancy; Serotonin; Serotonin Agents; Superoxide Dismutase | 1995 |
Intracerebral haemorrhage due to amphetamine abuse: report of two cases with underlying arteriovenous malformations.
Topics: Adult; Amphetamine; Cerebral Cortex; Cerebral Hemorrhage; Female; Humans; Intracranial Arteriovenous Malformations; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders | 1995 |
Microwave-induced rapid preparation of fluoro-derivatives of amphetamine, methamphetamine, and 3,4-methylenedioxymethamphetamine for GC-MS confirmation assays.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Calibration; Designer Drugs; Fluorides; Gas Chromatography-Mass Spectrometry; Methamphetamine; Microwaves; N-Methyl-3,4-methylenedioxyamphetamine; Phentermine | 1994 |
Effects of L-type calcium channel antagonists on the serotonin-depleting actions of MDMA in rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Chemistry; Calcium Channel Blockers; Cerebral Cortex; Flunarizine; Haloperidol; Hippocampus; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nifedipine; Rats; Rats, Sprague-Dawley; Seizures; Serotonin; Stereotyped Behavior; Verapamil | 1993 |
Simultaneous identification of amphetamine and its derivatives in urine using HPLC-UV.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Chromatography, High Pressure Liquid; Gas Chromatography-Mass Spectrometry; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Treatment Centers; Substance-Related Disorders; Ultraviolet Rays | 1993 |
The interactions of MK-801 with the amphetamine analogues D-methamphetamine (D-METH), 3,4-methylenedioxymethamphetamine (D-MDMA) or D-fenfluramine (D-FEN): neural damage and neural protection.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Biomarkers; Brain; Cerebral Cortex; Corpus Striatum; Dizocilpine Maleate; Female; Fenfluramine; Glial Fibrillary Acidic Protein; Hippocampus; Methamphetamine; Mice; Mice, Inbred C57BL; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Neurotoxins | 1993 |
Effects of glutamate antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine-induced striatal dopamine release in vivo.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amines; Animals; Corpus Striatum; Dizocilpine Maleate; Dopamine; Excitatory Amino Acid Antagonists; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pipecolic Acids; Rats; Rats, Sprague-Dawley | 1996 |
Detection of methamphetamine in sweat by EIA and GC-MS.
Topics: Calibration; Cross Reactions; Drug Interactions; Gas Chromatography-Mass Spectrometry; Humans; Immunoenzyme Techniques; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reference Standards; Reproducibility of Results; ROC Curve; Sweat | 1996 |
Ecstasy induced retropharyngeal emphysema.
Topics: Adult; Central Nervous System Stimulants; Emphysema; Hallucinogens; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pharyngeal Diseases; Radiography; Substance-Related Disorders | 1996 |
Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Body Temperature; Brain; Catecholamines; Corpus Striatum; Dopamine; Frontal Lobe; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Isosorbide Dinitrate; Male; Methamphetamine; Mice; Mice, Inbred Strains; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Sprague-Dawley; Serotonin | 1997 |
Quantitative and qualitative analysis of MDMA, MDEA, MA and amphetamine in urine by headspace/solid phase micro-extraction (SPME) and GC/MS.
Topics: 3,4-Methylenedioxyamphetamine; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine | 1996 |
Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Gas Chromatography-Mass Spectrometry; Hair; Hallucinogens; Humans; Lactates; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Substance Abuse Detection; Substance-Related Disorders | 1997 |
Enantioselective determination of 3,4-methylene-dioxymethamphetamine and two of its metabolites in human urine by cyclodextrin-modified capillary zone electrophoresis.
Topics: 3,4-Methylenedioxyamphetamine; Cyclodextrins; Dopamine; Electrophoresis, Capillary; Humans; Methamphetamine; Molecular Conformation; N-Methyl-3,4-methylenedioxyamphetamine | 1997 |
Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6.
Topics: Cytochrome P-450 CYP2D6; Humans; Methamphetamine; Microsomes, Liver; N-Methyl-3,4-methylenedioxyamphetamine; Oxidation-Reduction; Saccharomyces cerevisiae | 1997 |
Differential toxic effects of methamphetamine (METH) and methylenedioxymethamphetamine (MDMA) in multidrug-resistant (mdr1a) knockout mice.
Topics: Animals; Binding Sites; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Genes, MDR; Male; Methamphetamine; Mice; Mice, Knockout; Mice, Mutant Strains; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Serotonin Agents | 1997 |
Chest pain in a young girl.
Topics: Adult; Female; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pneumopericardium; Radiography | 1998 |
3-4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function.
Topics: Animals; Carrier Proteins; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Hallucinogens; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neostriatum; Nerve Tissue Proteins; Propiophenones; Rats; Rats, Sprague-Dawley; Synaptosomes | 1998 |
[Entactogenic drugs "ecstasy" (MDMA), "eve" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?].
Topics: 3,4-Methylenedioxyamphetamine; Designer Drugs; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Psychoses, Substance-Induced; Risk Factors | 1997 |
Amphetamine derivative fatalities in South Australia--is "Ecstasy" the culprit?
Topics: Adult; Australia; Central Nervous System Stimulants; Cerebral Hemorrhage; Drug Overdose; Fatal Outcome; Female; Fever; Hallucinogens; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Retrospective Studies | 1998 |
Necrotizing renal vasculopathy resulting in chronic renal failure after ingestion of methamphetamine and 3,4-methylenedioxymethamphetamine ('ecstasy')
Topics: Adult; Biopsy; Fatal Outcome; Glucocorticoids; Humans; Kidney Failure, Chronic; Kidney Papillary Necrosis; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Renal Dialysis; Vasculitis | 1998 |
Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems.
Topics: Animals; Caudate Nucleus; Central Nervous System Stimulants; Cocaine; Extrapyramidal Tracts; Globus Pallidus; Limbic System; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neuropeptide Y; Nucleus Accumbens; Phencyclidine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Substantia Nigra | 1999 |
Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons.
Topics: 3,4-Methylenedioxyamphetamine; Alternative Splicing; Amphetamines; Animals; Apoptosis; bcl-X Protein; Dextroamphetamine; DNA Fragmentation; Gene Expression Regulation; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neocortex; Neurons; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar | 1999 |
Distinct features of seizures induced by cocaine and amphetamine analogs.
Topics: Animals; Central Nervous System Agents; Central Nervous System Stimulants; Diazepam; Dose-Response Relationship, Drug; Flunarizine; Hallucinogens; Male; Methamphetamine; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Oxazoles; Rats; Rats, Sprague-Dawley; Seizures; Time Factors; Valproic Acid | 1999 |
Simultaneous determination of amphetamine, methamphetamine, methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA), and methylenedioxyethylamphetamine (MDEA) enantiomers by GC-MS.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Central Nervous System Stimulants; Gas Chromatography-Mass Spectrometry; Humans; In Vitro Techniques; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Sensitivity and Specificity; Stereoisomerism; Substance Abuse Detection; Time Factors; Urine | 1999 |
Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse.
Topics: Adrenergic Uptake Inhibitors; Animals; Dopamine; Dopamine Uptake Inhibitors; Indans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Substance-Related Disorders | 2000 |
Hair analysis: self-reported use of "speed" and "ecstasy" compared with laboratory findings.
Topics: Adolescent; Adult; Central Nervous System Stimulants; False Negative Reactions; False Positive Reactions; Female; Forensic Medicine; Gas Chromatography-Mass Spectrometry; Hair; Hallucinogens; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Substance-Related Disorders | 2000 |
Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration.
Topics: Adrenergic Uptake Inhibitors; Animals; Body Temperature; Brain; Brain Mapping; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Electron Transport Complex IV; Male; Methamphetamine; Mitochondria; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Time Factors | 2000 |
High-resolution solid state 13C nuclear magnetic resonance spectra of 3,4-methylenedioxyamphetamine hydrochloride and related compounds and their mixtures with lactose.
Topics: 3,4-Methylenedioxyamphetamine; Carbon Isotopes; Crystallization; Ephedrine; Hydrogen Bonding; Lactose; Magnetic Resonance Spectroscopy; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Solutions; Stereoisomerism | 2000 |
Long-term induction of Fos-related antigen-2 after methamphetamine-, methylenedioxymethamphetamine-, 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine- and trimethyltin-induced brain injury.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain Diseases; DNA-Binding Proteins; Dopamine Agents; Fos-Related Antigen-2; Immunohistochemistry; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Time Factors; Transcription Factors; Trimethyltin Compounds | 2000 |
A re-examination of the mono-methoxy positional ring isomers of amphetamine, methamphetamine and phenyl-2-propanone.
Topics: Acetone; Amphetamine; Amphetamines; Cause of Death; Chemistry, Pharmaceutical; Forensic Medicine; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Isomerism; Magnetic Resonance Spectroscopy; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Spectrophotometry, Infrared; Substance Abuse Detection; United States | 2001 |
Application of SERS spectroscopy to the identification of (3,4-methylenedioxy)amphetamine in forensic samples utilizing matrix stabilized silver halides.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Spectrum Analysis, Raman | 2001 |
Drug dependence studies and regulations: an overview of the past and present.
Topics: Cannabis; Drug and Narcotic Control; Forecasting; History, 20th Century; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Oxycodone; Sodium Oxybate; Substance-Related Disorders; United States | 2001 |
Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
Topics: Animals; Biological Transport; Body Temperature; Cell Membrane; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Hallucinogens; Kinetics; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Neuropeptides; Neurotoxins; Rats; Rats, Sprague-Dawley; Synaptic Vesicles; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2002 |
Effect of PMA optical isomers and 4-MTA in PMMA-trained rats.
Topics: Animals; Discrimination Learning; Dose-Response Relationship, Drug; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Stereoisomerism | 2002 |
Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Amphetamines; Animals; Caudate Nucleus; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Methamphetamine; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin | 2002 |
Quantitation of amphetamine, methamphetamine, and their methylenedioxy derivatives in urine by solid-phase microextraction coupled with electrospray ionization-high-field asymmetric waveform ion mobility spectrometry-mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Central Nervous System Stimulants; Hallucinogens; Humans; Indicators and Reagents; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection | 2002 |
Inhibition of the alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase complexes by a putative aberrant metabolite of serotonin, tryptamine-4,5-dione.
Topics: Animals; Brain; Central Nervous System Stimulants; Enzyme Inhibitors; Indolequinones; Ketoglutarate Dehydrogenase Complex; Male; Methamphetamine; Mitochondria; N-Methyl-3,4-methylenedioxyamphetamine; Pyruvate Dehydrogenase Complex; Rats; Rats, Sprague-Dawley; Tryptamines | 2002 |
What are club drugs? Here's a quick look.
Topics: Designer Drugs; Humans; Ketamine; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Sodium Oxybate | 2002 |
Development of a rapid and sensitive method for the quantitation of amphetamines in human plasma and oral fluid by LC-MS-MS.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Chromatography, Liquid; Ephedrine; Humans; Mass Spectrometry; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Saliva; Substance Abuse Detection | 2003 |
Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity.
Topics: Animals; Binding Sites; Body Weight; Brain; Carrier Proteins; Central Nervous System Diseases; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drug Administration Schedule; Fever; Glial Fibrillary Acidic Protein; Heat-Shock Proteins; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Neuroglia; Rats; Rats, Sprague-Dawley; Serotonin; Time Factors | 2003 |
Behavioural changes in rats treated with a neurotoxic dose regimen of dextrorotatory amphetamine derivatives.
Topics: Animals; Avoidance Learning; Central Nervous System Stimulants; Male; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Stereoisomerism | 2003 |
Confirmation of amphetamine, methamphetamine, MDA and MDMA in urine samples using disk solid-phase extraction and gas chromatography-mass spectrometry after immunoassay screening.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Gas Chromatography-Mass Spectrometry; Immunoassay; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine | 2003 |
Agony for researchers as mix-up forces retraction of ecstasy study.
Topics: Animals; Brain; Drug Labeling; Haplorhini; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; National Institutes of Health (U.S.); Retraction of Publication as Topic; United States | 2003 |
Retraction. Paper on toxic party drug is pulled over vial mix-up.
Topics: Animals; Dopamine; Drug Labeling; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Parkinson Disease; Primates; Retraction of Publication as Topic; Risk Factors | 2003 |
Ecstasy's after-effects.
Topics: Animals; Haplorhini; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; National Institutes of Health (U.S.); Politics; Retraction of Publication as Topic; Substance-Related Disorders; United States | 2003 |
Pointless suffering of animals can be avoided.
Topics: Animal Welfare; Animals; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Retraction of Publication as Topic; Retrospective Studies | 2003 |
Amphetamines induce ubiquitin-positive inclusions within striatal cells.
Topics: Adrenergic Uptake Inhibitors; Animals; Cell Count; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Glutamate Decarboxylase; Inclusion Bodies; Isoenzymes; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Microscopy, Electron; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Ubiquitin | 2003 |
Performance characteristics of selected immunoassays for preliminary test of 3,4-methylenedioxymethamphetamine, methamphetamine, and related drugs in urine specimens.
Topics: Gas Chromatography-Mass Spectrometry; Humans; Immunoassay; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reference Standards; Sensitivity and Specificity; Specimen Handling; Substance Abuse Detection | 2003 |
Development and validation of a gas chromatography-mass spectrometry assay for hair analysis of amphetamine, methamphetamine and methylenedioxy derivatives.
Topics: Amphetamine; Gas Chromatography-Mass Spectrometry; Hair; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Sensitivity and Specificity | 2003 |
A contextual profile of club drug use among adults in Chicago.
Topics: Adolescent; Adult; Central Nervous System Stimulants; Chicago; Ethnicity; Female; Hallucinogens; Humans; Illicit Drugs; Lysergic Acid Diethylamide; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Risk Factors; Sex Factors; Sexual Behavior; Social Behavior; Substance-Related Disorders | 2003 |
Circuit parties and patterns of drug use in a subset of gay men.
Topics: Adult; Anniversaries and Special Events; Female; HIV Infections; Homosexuality, Male; Humans; Ketamine; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; New York; Risk-Taking; Sexual Behavior; Sodium Oxybate; Substance-Related Disorders | 2003 |
Evaluation of ephedrine, pseudoephedrine and phenylpropanolamine concentrations in human urine samples and a comparison of the specificity of DRI amphetamines and Abuscreen online (KIMS) amphetamines screening immunoassays.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Central Nervous System Stimulants; Ephedrine; False Positive Reactions; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Immunoassay; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Online Systems; Phenylpropanolamine; Reagent Kits, Diagnostic; Substance Abuse Detection; Sympathomimetics | 2004 |
Acute, transient urinary retention from combined ecstasy and methamphetamine use.
Topics: Acute Disease; Adolescent; Alcohol Drinking; Amphetamine-Related Disorders; Emergency Medical Services; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Treatment Outcome; Urinary Catheterization; Urinary Retention | 2004 |
MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat.
Topics: Animals; Anxiety; Behavior, Animal; Body Temperature; Corpus Striatum; Dopamine; Dopamine Agents; Drug Interactions; Fever; Hot Temperature; Hydroxyindoleacetic Acid; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Serotonin; Serotonin Agents; Social Behavior | 2004 |
Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys.
Topics: Animals; Behavior, Animal; Biogenic Monoamines; Brain; Brain Chemistry; Brain Mapping; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Cocaine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Electrochemistry; Infusions, Intravenous; Macaca mulatta; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Radioligand Assay; ROC Curve; Self Administration; Serotonin Agents; Stereoisomerism; Tetrabenazine; Tissue Distribution; Tomography, Emission-Computed; Tritium | 2004 |
Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism.
Topics: Adrenergic Uptake Inhibitors; Amphetamine-Related Disorders; Animals; Blotting, Western; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Fever; Macromolecular Substances; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Molecular Weight; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Time | 2004 |
Application of ORAL.screen saliva drug test for the screening of methamphetamine, MDMA, and MDEA incorporated in hair.
Topics: 3,4-Methylenedioxyamphetamine; Forensic Medicine; Hair; Humans; Immunoassay; Immunochemistry; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reagent Kits, Diagnostic; Saliva; Substance Abuse Detection | 2004 |
Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells.
Topics: alpha-Tocopherol; Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Caspase 3; Caspases; Cerebellum; Cytochromes c; Dizocilpine Maleate; Drug Interactions; Enzyme Activation; Flow Cytometry; Methamphetamine; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Mitochondria; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Neuroprotective Agents; Quinoxalines; Rats; Reactive Oxygen Species | 2004 |
Amphetamines and 3,4-methylendioxymetamphetamine (MDMA): evaluation of KIMS (kinetic interaction of microparticles in solution) assay at two cut-off levels.
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Amphetamines; Chromatography, High Pressure Liquid; Clinical Chemistry Tests; Enzyme Multiplied Immunoassay Technique; Female; Gas Chromatography-Mass Spectrometry; Humans; Immunoassay; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Nanostructures; Predictive Value of Tests; Sensitivity and Specificity; Substance-Related Disorders | 2004 |
Unprotected anal intercourse associated with recreational drug use among young men who have sex with men depends on partner type and intercourse role.
Topics: Adult; Alcohol Drinking; British Columbia; Cannabis; Cohort Studies; HIV Infections; Homosexuality, Male; Humans; Ketamine; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Prospective Studies; Safe Sex; Sexual Partners; Substance-Related Disorders | 2004 |
Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines.
Topics: Amphetamine; Analysis of Variance; Animals; Blotting, Western; Cell Count; Corpus Striatum; Dopamine Agents; Female; Glial Fibrillary Acidic Protein; Immunohistochemistry; Lectins; Methamphetamine; Mice; Mice, Inbred C57BL; Microglia; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine | 2004 |
UCP3 and thyroid hormone involvement in methamphetamine-induced hyperthermia.
Topics: Animals; Body Temperature; Carrier Proteins; Hyperthermia, Induced; Ion Channels; Male; Methamphetamine; Mice; Mitochondrial Proteins; Muscle, Skeletal; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Rectum; Thyroid Hormones; Uncoupling Protein 3 | 2004 |
Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA).
Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamine; Canada; Cocaine; Dopamine Uptake Inhibitors; Drug Contamination; Female; Forensic Medicine; Gas Chromatography-Mass Spectrometry; Hair; Hallucinogens; Humans; Illicit Drugs; Male; Methamphetamine; Molecular Structure; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine | 2004 |
The neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine on serotonin, dopamine, and GABA-ergic terminals: an in-vitro autoradiographic study in rats.
Topics: Animals; Female; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Presynaptic Terminals; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, GABA; Receptors, Serotonin | 2004 |
Enantiomeric separation and quantitation of (+/-)-amphetamine, (+/-)-methamphetamine, (+/-)-MDA, (+/-)-MDMA, and (+/-)-MDEA in urine specimens by GC-EI-MS after derivatization with (R)-(-)- or (S)-(+)-alpha-methoxy-alpha-(trifluoromethy)phenylacetyl chlor
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Chromatography, Gas; Chromatography, Ion Exchange; Humans; Indicators and Reagents; Methamphetamine; Military Personnel; N-Methyl-3,4-methylenedioxyamphetamine; Quaternary Ammonium Compounds; Reference Standards; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism; Substance Abuse Detection | 2004 |
Differential response of nNOS knockout mice to MDMA ("ecstasy")- and methamphetamine-induced psychomotor sensitization and neurotoxicity.
Topics: Animals; Brain; Male; Methamphetamine; Mice; Mice, Knockout; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Psychomotor Performance | 2004 |
Club drugs: reasons for and consequences of use.
Topics: Adolescent; Adult; Central Nervous System Stimulants; Dextromethorphan; Female; Flunitrazepam; Hallucinogens; Humans; Illicit Drugs; Interviews as Topic; Ketamine; Life Style; Lysergic Acid Diethylamide; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Sodium Oxybate; Substance-Related Disorders; United States | 2004 |
[Speed users (metamphetamines): a return journey between ecstasy (MDMA) and cocaine. Clinical, preventive and health-care questions].
Topics: Adolescent; Adult; Central Nervous System Stimulants; Cocaine-Related Disorders; Hallucinogens; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders | 2004 |
Differential effects of amphetamines-induced neurotoxicity on appetitive and aversive Pavlovian conditioning in mice.
Topics: Amphetamines; Animals; Antimanic Agents; Appetitive Behavior; Avoidance Learning; Central Nervous System Stimulants; Conditioning, Classical; Dopamine; Fenfluramine; Hallucinogens; Lithium Chloride; Male; Methamphetamine; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Endings; Neurotoxicity Syndromes; Receptors, Serotonin; Reinforcement, Psychology; Reward; Serotonin | 2005 |
Effects of seven drugs of abuse on action potential repolarisation in sheep cardiac Purkinje fibres.
Topics: Action Potentials; Animals; Cocaine; Dose-Response Relationship, Drug; Dronabinol; Illicit Drugs; In Vitro Techniques; Male; Methamphetamine; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Purkinje Fibers; Sheep; Time Factors | 2005 |
MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
Topics: Animals; Behavior, Animal; Body Temperature; Brain; Brain Chemistry; Central Nervous System Stimulants; Drug Administration Schedule; Drug Combinations; Female; Fever; Hallucinogens; Head Movements; Hydroxyindoleacetic Acid; Interpersonal Relations; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Serotonin; Swimming; Time Factors | 2005 |
Club drug use among young men who have sex with men in NYC: a preliminary epidemiological profile.
Topics: Adolescent; Adult; Anesthetics, Dissociative; Central Nervous System Stimulants; Chronic Disease; Cross-Sectional Studies; Hallucinogens; Health Surveys; Homosexuality; Humans; Ketamine; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; New York City; Recreation; Risk-Taking; Sexually Transmitted Diseases; Substance-Related Disorders; Suicide, Attempted; Urban Population | 2005 |
Plasma drug concentrations and physiological measures in 'dance party' participants.
Topics: Adult; Body Temperature; Dancing; Demography; Female; Hallucinogens; Heart Rate; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Radioimmunoassay; Surveys and Questionnaires | 2006 |
Pizotyline effectively attenuates the stimulus effects of N-methyl-3,4-methylenedioxyamphetamine (MDMA).
Topics: Animals; Central Nervous System Stimulants; Cyproheptadine; Discrimination, Psychological; Dose-Response Relationship, Drug; Generalization, Psychological; Hallucinogens; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pizotyline; Rats; Rats, Sprague-Dawley; Receptors, Neurotransmitter; Receptors, Serotonin; Serotonin Antagonists | 2005 |
Rapid analysis of controlled substances using desorption electrospray ionization mass spectrometry.
Topics: Acetaminophen; Alprazolam; Cannabis; Drug Combinations; Hydrocodone; Legislation, Drug; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pharmaceutical Preparations; Prednisone; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection; Time Factors | 2006 |
Methylone and mCPP, two new drugs of abuse?
Topics: Adrenergic Uptake Inhibitors; Biogenic Monoamines; Cross-Sectional Studies; Designer Drugs; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Netherlands; Piperazines; Receptors, Serotonin; Serotonin Receptor Agonists; Substance-Related Disorders | 2005 |
Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
Topics: Adult; Amphetamine-Related Disorders; Australia; Comorbidity; Cross-Sectional Studies; Female; Hallucinogens; Hepatitis B; Hepatitis B Vaccines; Hepatitis C; Heroin Dependence; Humans; Illicit Drugs; Interview, Psychological; Male; Mass Screening; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Needle Sharing; Population Surveillance; Risk-Taking; Sexual Behavior; Socioeconomic Factors; Substance Abuse, Intravenous; Surveys and Questionnaires; Urban Population | 2006 |
Development of murine monoclonal antibodies to methamphetamine and methamphetamine analogues.
Topics: Animals; Antibodies, Monoclonal; Antibody Affinity; Antibody Specificity; Haptens; Humans; Hybridomas; Illicit Drugs; Immunotherapy; In Vitro Techniques; Methamphetamine; Mice; Mice, Inbred BALB C; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders | 2006 |
Differentiation of amphetamine/methamphetamine and other cross-immunoreactive sympathomimetic amines in urine samples by serial dilution testing.
Topics: Amphetamine; Cross Reactions; Ephedrine; Humans; Immunoassay; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; ROC Curve; Substance Abuse Detection; Sympathomimetics | 2006 |
Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths.
Topics: Adolescent; Adult; Age of Onset; Data Collection; Demography; Female; Flunitrazepam; Humans; Incidence; Ketamine; Lysergic Acid Diethylamide; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Sodium Oxybate; Substance-Related Disorders | 2006 |
Increased risk of "club" drug use among gay and bisexual high school students in British Columbia.
Topics: Adolescent; Adult; Anesthetics, Dissociative; Bisexuality; British Columbia; Central Nervous System Stimulants; Female; Hallucinogens; Health Surveys; Homosexuality; Humans; Ketamine; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Odds Ratio; Recreation; Risk Factors; Students; Substance-Related Disorders | 2006 |
A validated gas chromatographic-electron impact ionization mass spectrometric method for methylenedioxymethamphetamine (MDMA), methamphetamine and metabolites in oral fluid.
Topics: Chromatography, Gas; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Saliva; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2006 |
Prostaglandin H synthase-catalyzed bioactivation of amphetamines to free radical intermediates that cause CNS regional DNA oxidation and nerve terminal degeneration.
Topics: 3,4-Methylenedioxyamphetamine; Adrenergic Uptake Inhibitors; Amphetamines; Animals; Aspirin; Brain; Cyclooxygenase Inhibitors; DNA; Dose-Response Relationship, Drug; Female; Free Radicals; Methamphetamine; Mice; Molecular Structure; N-Methyl-3,4-methylenedioxyamphetamine; Oxidation-Reduction; Prostaglandin-Endoperoxide Synthases; Psychomotor Performance; Synapses | 2006 |
Differences in club drug use between heterosexual and lesbian/bisexual females.
Topics: Adolescent; Adult; Age Factors; Amphetamine-Related Disorders; Bisexuality; Cocaine-Related Disorders; Female; Gender Identity; Homosexuality, Female; Humans; Illicit Drugs; Ketamine; Lysergic Acid Diethylamide; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; New York City; Sexuality; Sodium Oxybate; Substance-Related Disorders | 2006 |
Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease.
Topics: Amphetamines; Animals; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Electrochemistry; Fluoxetine; Heart Diseases; Hydroxyindoleacetic Acid; Indicators and Reagents; Lung Diseases; Male; Methamphetamine; Microdialysis; Mitogens; Muscle, Smooth, Vascular; N-Methyl-3,4-methylenedioxyamphetamine; Phentermine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Stimulation, Chemical | 2006 |
Sensitive, rapid and validated gas chromatography/negative ion chemical ionization-mass spectrometry assay including derivatisation with a novel chiral agent for the enantioselective quantification of amphetamine-type stimulants in hair.
Topics: Amphetamines; Gas Chromatography-Mass Spectrometry; Hair; Humans; Methamphetamine; Molecular Structure; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Stereoisomerism | 2006 |
Editorial: ocular effects of criminal drug use.
Topics: Cannabis; Cocaine; Eye Diseases; Heroin; Humans; Illicit Drugs; Lysergic Acid Diethylamide; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine | 2006 |
Chiral separation and quantification of R/S-amphetamine, R/S-methamphetamine, R/S-MDA, R/S-MDMA, and R/S-MDEA in whole blood by GC-EI-MS.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Chromatography, Gas; Humans; Methamphetamine; Molecular Structure; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism; Substance Abuse Detection | 2006 |
Sensitive gas chromatography-mass spectrometry method for simultaneous measurement of MDEA, MDMA, and metabolites HMA, MDA, and HMMA in human urine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Calibration; Central Nervous System Stimulants; Dopamine; Gas Chromatography-Mass Spectrometry; Humans; Hydrolysis; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Sensitivity and Specificity; Substance Abuse Detection | 2006 |
Analysis of amphetamine, methamphetamine and methylenedioxy-methamphetamine by micellar capillary electrophoresis using cation-selective exhaustive injection.
Topics: Amphetamine; Cations; Central Nervous System Stimulants; Chromatography, Micellar Electrokinetic Capillary; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Online Systems; Reproducibility of Results; Sensitivity and Specificity; Sodium Dodecyl Sulfate | 2006 |
The study of metabolite-to-parent drug ratios of methamphetamine and methylenedioxymethamphetamine in hair.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Biotransformation; Female; Gas Chromatography-Mass Spectrometry; Hair; Humans; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection | 2006 |
Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Behavior, Animal; Body Temperature; Dose-Response Relationship, Drug; Hallucinogens; Macaca mulatta; Male; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Time Factors | 2006 |
Calpain- and caspase-mediated alphaII-spectrin and tau proteolysis in rat cerebrocortical neuronal cultures after ecstasy or methamphetamine exposure.
Topics: Amino Acid Chloromethyl Ketones; Animals; Animals, Newborn; Aspartic Acid; Calpain; Caspase Inhibitors; Caspases; Cell Death; Cells, Cultured; Cerebral Cortex; Cysteine Proteinase Inhibitors; Dipeptides; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Methamphetamine; Microfilament Proteins; Molecular Weight; N-Methyl-3,4-methylenedioxyamphetamine; N-Methylaspartate; Neurons; Peptide Fragments; Psychotropic Drugs; Rats; Rats, Sprague-Dawley; tau Proteins; Time Factors; Vesicular Transport Proteins | 2007 |
Repeated weekly exposure to MDMA, methamphetamine or their combination: long-term behavioural and neurochemical effects in rats.
Topics: Animals; Anxiety; Behavior, Animal; Brain; Brain Chemistry; Drug Interactions; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Rats; Rats, Wistar; Serotonin; Social Behavior; Time | 2007 |
Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphetamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine.
Topics: Amphetamine-Related Disorders; Amphetamines; Animals; Attention; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Cognition Disorders; Dextroamphetamine; Hallucinogens; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Perceptual Disorders; Psychomotor Performance; Rats; Reaction Time; Substance Withdrawal Syndrome; Time; Visual Perception | 2007 |
Estimating the relative reinforcing strength of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) and its isomers in rhesus monkeys: comparison to (+)-methamphetamine.
Topics: Animals; Behavior, Animal; Brain; Central Nervous System Stimulants; Cocaine; Dopamine; Dose-Response Relationship, Drug; Isomerism; Macaca mulatta; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reinforcement Schedule; Reinforcement, Psychology; Self Administration; Serotonin; Serotonin Agents; Structure-Activity Relationship | 2007 |
The effect of amphetamine analogs on cleaved microtubule-associated protein-tau formation in the rat brain.
Topics: 5,7-Dihydroxytryptamine; Amphetamines; Animals; Brain Chemistry; Data Interpretation, Statistical; Dopamine; Glial Fibrillary Acidic Protein; Immunohistochemistry; Male; Methamphetamine; Microtubule-Associated Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; tau Proteins | 2007 |
Ecstasy toxicity: a comparison to methamphetamine and traumatic brain injury.
Topics: Animals; Brain; Brain Injuries; Central Nervous System Stimulants; Cerebral Cortex; Electrophoresis, Polyacrylamide Gel; Hallucinogens; Hippocampus; Immunoblotting; Liver; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Spectrin; Substance-Related Disorders; tau Proteins | 2006 |
Intravenous methamphetamine self-administration in rats: effects of intravenous or intraperitoneal MDMA co-administration.
Topics: Animals; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Injections, Intravenous; Male; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Reinforcement Schedule; Self Administration | 2006 |
Determination of amphetamines in human urine by liquid chromatography with fluorimetric detection using a solid-phase extraction procedure.
Topics: Amphetamines; Chromatography, High Pressure Liquid; Fluorometry; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Solid Phase Extraction; Substance Abuse Detection | 2006 |
Selection and optimization of hydrolysis conditions for the quantification of urinary metabolites of MDMA.
Topics: 3,4-Methylenedioxyamphetamine; Dopamine; Forensic Toxicology; Glucuronidase; Hallucinogens; Humans; Hydrochloric Acid; Hydrolysis; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection | 2006 |
A validated SPME-GC-MS method for simultaneous quantification of club drugs in human urine.
Topics: Central Nervous System Agents; Forensic Toxicology; Formates; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; Indicators and Reagents; Ketamine; Methamphetamine; Molecular Structure; N-Methyl-3,4-methylenedioxyamphetamine; Pyridines; Sodium Oxybate; Solid Phase Microextraction; Substance Abuse Detection | 2007 |
N-Methyl-1-(4-methoxyphenyl)-2-aminopropane (PMMA) and N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) produce non-identical discriminative stimuli in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Cocaine; Discrimination, Psychological; Illicit Drugs; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship | 2007 |
The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cohort Studies; HIV Seropositivity; Homosexuality, Male; Humans; Male; Methamphetamine; Multicenter Studies as Topic; Multivariate Analysis; N-Methyl-3,4-methylenedioxyamphetamine; Risk Factors; Sexual Behavior; Sexual Partners; Substance-Related Disorders; Time Factors | 2007 |
Inhibition by cocaine of G protein-activated inwardly rectifying K+ channels expressed in Xenopus oocytes.
Topics: Animals; Brain Chemistry; Central Nervous System Stimulants; Cocaine; Dose-Response Relationship, Drug; Electrophysiology; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Heart; Methamphetamine; Methylphenidate; Mice; Myocardium; N-Methyl-3,4-methylenedioxyamphetamine; Plasmids; Potassium Channel Blockers; RNA, Messenger; Xenopus laevis | 2007 |
Roadside drug testing: unanswered questions and future challenges.
Topics: Australia; Automobile Driving; Breath Tests; Cannabis; Forecasting; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Substance-Related Disorders | 2007 |
The effects of p-chloroamphetamine, methamphetamine and 3,4-methylenedioxymethamphetamine (ecstasy) on the gene expression of cytoskeletal proteins in the rat brain.
Topics: Actins; Animals; Blotting, Western; Brain Mapping; Central Nervous System Stimulants; Cerebral Cortex; Cytoskeletal Proteins; Dose-Response Relationship, Drug; Gene Expression; In Situ Hybridization; Injections, Intraperitoneal; Male; Methamphetamine; Microtubule-Associated Proteins; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine; Rats; Rats, Wistar; Survival Analysis | 2007 |
Oral administration of (+/-)3,4-methylenedioxymethamphetamine and (+)methamphetamine alters temperature and activity in rhesus macaques.
Topics: Administration, Oral; Animals; Body Temperature; Body Temperature Regulation; Central Nervous System Stimulants; Data Interpretation, Statistical; Injections, Intramuscular; Macaca mulatta; Male; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Serotonin Agents; Stereoisomerism; Telemetry | 2007 |
Pharmacological and behavioral determinants of cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, and para-methoxyamphetamine-induced hyperthermia.
Topics: Amphetamines; Animals; Behavior, Animal; Body Temperature Regulation; Central Nervous System Stimulants; Cerebral Cortex; Cocaine; Dopamine; Dose-Response Relationship, Drug; Fever; Humans; Injections, Intraperitoneal; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin; Sodium Chloride; Time Factors | 2007 |
Evaluation of a rapid oral fluid point-of-care test for MDMA.
Topics: Gas Chromatography-Mass Spectrometry; Hallucinogens; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Point-of-Care Systems; Reproducibility of Results; Saliva; Sensitivity and Specificity; Substance Abuse Detection | 2007 |
Analysis of MDMA and its metabolites in urine and plasma following a neurotoxic dose of MDMA.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Biotransformation; Calibration; Dopamine; Gas Chromatography-Mass Spectrometry; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Psychotropic Drugs; Rats; Reproducibility of Results; Toxicology | 2007 |
Methamphetamine and 3,4-methylenedioxymethamphetamine interact with central nicotinic receptors and induce their up-regulation.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Binding, Competitive; Brain; Cell Membrane; Dose-Response Relationship, Drug; Male; Methamphetamine; Mice; N-Methyl-3,4-methylenedioxyamphetamine; PC12 Cells; Radioligand Assay; Rats; Receptors, Nicotinic; Time Factors; Up-Regulation | 2007 |
Interactions between 3,4-methylenedioxymethamphetamine, methamphetamine, ketamine, and caffeine in human intestinal Caco-2 cells and in oral administration to rats.
Topics: Administration, Oral; Anesthetics, Dissociative; Animals; Area Under Curve; Caco-2 Cells; Caffeine; Cells, Cultured; Central Nervous System Stimulants; Drug Interactions; Forensic Toxicology; Hallucinogens; Humans; Intestinal Absorption; Intestinal Mucosa; Ketamine; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar | 2007 |
Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine-Related Disorders; Calibration; Designer Drugs; Gas Chromatography-Mass Spectrometry; Glucuronides; Hallucinogens; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Substance Abuse Detection; Sulfates | 2007 |
Validated liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxym
Topics: 3,4-Methylenedioxyamphetamine; Animals; Calibration; Chromatography, Liquid; Deoxyepinephrine; Hallucinogens; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Saimiri; Spectrometry, Mass, Electrospray Ionization | 2007 |
Calpain and caspase proteolytic markers co-localize with rat cortical neurons after exposure to methamphetamine and MDMA.
Topics: Animals; Apoptosis; Biomarkers; Blotting, Western; Calpain; Caspase 3; Central Nervous System Stimulants; Cerebral Cortex; Enzyme Activation; Immunohistochemistry; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Rats; Rats, Sprague-Dawley; Spectrin | 2007 |
Drugs in oral fluid in randomly selected drivers.
Topics: Adolescent; Adult; Australia; Automobile Driving; Central Nervous System Stimulants; Dronabinol; Female; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Saliva; Substance Abuse Detection | 2007 |
Changes in leptin, ghrelin, growth hormone and neuropeptide-Y after an acute model of MDMA and methamphetamine exposure in rats.
Topics: Adrenergic Uptake Inhibitors; Amphetamine-Related Disorders; Animals; Appetite; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Ghrelin; Growth Hormone; Leptin; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neuropeptide Y; Radioimmunoassay; Rats; Rats, Sprague-Dawley | 2008 |
Short- and long-term effects of (+)-methamphetamine and (+/-)-3,4-methylenedioxymethamphetamine on monoamine and corticosterone levels in the neonatal rat following multiple days of treatment.
Topics: Adrenergic Uptake Inhibitors; Animals; Animals, Newborn; Biogenic Monoamines; Body Weight; Corticosterone; Female; Hippocampus; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neostriatum; Pregnancy; Rats; Rats, Sprague-Dawley | 2008 |
A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse.
Topics: Animals; Behavior, Animal; Body Temperature; Body Weight; Brain; Brain Chemistry; Central Nervous System Stimulants; Cerebral Cortex; Data Interpretation, Statistical; Dopamine; Hallucinogens; Isoquinolines; Male; Methamphetamine; Mice; Microglia; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Neostriatum | 2008 |
Direct injection LC-MS/MS method for identification and quantification of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in urine drug testing.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Chromatography, Liquid; Gas Chromatography-Mass Spectrometry; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Substance Abuse Detection; Tandem Mass Spectrometry | 2008 |
Two-dimensional gas chromatography/electron-impact mass spectrometry with cryofocusing for simultaneous quantification of MDMA, MDA, HMMA, HMA, and MDEA in human plasma.
Topics: 3,4-Methylenedioxyamphetamine; Calibration; Central Nervous System Stimulants; Dopamine; Gas Chromatography-Mass Spectrometry; Humans; Hydrolysis; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Substance Abuse Detection | 2008 |
What evidence is there that the UK should tackle the potential emerging threat of methamphetamine toxicity rather than established recreational drugs such as MDMA ('ecstasy')?
Topics: Adult; Central Nervous System Stimulants; Drug and Narcotic Control; Drug Overdose; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Retrospective Studies; Substance Abuse Detection; United Kingdom | 2008 |
Impulsivity in Hong Kong-Chinese club-drug users.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Asian People; Cross-Cultural Comparison; Cross-Sectional Studies; Drive; Exploratory Behavior; Female; Hong Kong; Humans; Illicit Drugs; Impulsive Behavior; Ketamine; Male; Marijuana Abuse; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Personality Inventory; Psychometrics; Punishment; Reproducibility of Results; Reward; Social Environment; Social Facilitation; Substance-Related Disorders | 2008 |
Rapid screening of methamphetamines in human serum by headspace solid-phase microextraction using a dodecylsulfate-doped polypyrrole film coupled to ion mobility spectrometry.
Topics: Electrochemistry; Humans; Hydrogen-Ion Concentration; Ions; Membranes, Artificial; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Polymers; Pyrroles; Sensitivity and Specificity; Sodium Dodecyl Sulfate; Solid Phase Microextraction; Spectrum Analysis; Temperature | 2008 |
Driving under the influence of central stimulant amines: age and gender differences in concentrations of amphetamine, methamphetamine, and ecstasy in blood.
Topics: Adult; Age Factors; Amphetamine; Amphetamine-Related Disorders; Automobile Driving; Central Nervous System Stimulants; Databases, Factual; Female; Forensic Toxicology; Humans; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Sex Factors; Substance Abuse Detection; Sweden | 2008 |
Problems in three Japanese drug users with Human Immunodeficiency Virus infection.
Topics: 5-Methoxytryptamine; Adult; Amyl Nitrite; Antiretroviral Therapy, Highly Active; Asian People; Drug Interactions; HIV Infections; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neuroleptic Malignant Syndrome; Rhabdomyolysis; Seizures; Substance-Related Disorders | 2008 |
Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
Topics: Adolescent; Adult; Age Factors; Amphetamine-Related Disorders; Australia; Central Nervous System Stimulants; Crime; Data Collection; Female; Heroin Dependence; HIV Infections; Humans; Illicit Drugs; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Risk-Taking; Sex Factors; Substance Abuse, Intravenous | 2008 |
Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
Topics: Adult; Amphetamine-Related Disorders; Australia; Central Nervous System Stimulants; Crime; Cross-Sectional Studies; Female; Hallucinogens; Harm Reduction; Heroin Dependence; Humans; Illicit Drugs; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Psychiatric Status Rating Scales; Risk-Taking; Severity of Illness Index; Substance Abuse, Intravenous; Substance-Related Disorders; Surveys and Questionnaires | 2008 |
Memantine protects against amphetamine derivatives-induced neurotoxic damage in rodents.
Topics: Animals; Benzamides; Body Temperature; Bridged Bicyclo Compounds; Dizocilpine Maleate; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Excitatory Amino Acid Antagonists; Hallucinogens; Hippocampus; Male; Memantine; Methamphetamine; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Neuroglia; Neuroprotective Agents; Neurotoxicity Syndromes; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Nicotinic; Serotonin Plasma Membrane Transport Proteins | 2008 |
Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and its analogues, on isolated rat hepatocytes.
Topics: 3,4-Methylenedioxyamphetamine; Adenosine Triphosphate; Animals; Cell Death; DNA Damage; Hallucinogens; Hepatocytes; Male; Methamphetamine; Mitochondria, Liver; N-Methyl-3,4-methylenedioxyamphetamine; Oxidative Phosphorylation; Rats; Rats, Inbred F344; Time Factors | 2009 |
Simultaneous determination of amphetamine-type stimulants and cannabinoids in fingernails by gas chromatography-mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamine-Related Disorders; Amphetamines; Dronabinol; Gas Chromatography-Mass Spectrometry; Humans; Marijuana Abuse; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nails; Observer Variation; Reproducibility of Results; Substance Abuse Detection | 2008 |
Multivariate modeling of club drug use initiation among gay and bisexual men.
Topics: Adolescent; Adult; Aged; Bisexuality; Cocaine; Homosexuality, Male; Humans; Ketamine; Longitudinal Studies; Male; Methamphetamine; Middle Aged; Models, Statistical; Multivariate Analysis; N-Methyl-3,4-methylenedioxyamphetamine; New York City; Social Behavior; Social Facilitation; Sodium Oxybate; Substance-Related Disorders | 2008 |
Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses.
Topics: Animals; Area Under Curve; Deoxyepinephrine; Half-Life; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Saimiri; Species Specificity | 2008 |
Development of a simultaneous liquid-liquid extraction and chiral derivatization method for stereospecific GC-MS analysis of amphetamine-type stimulants in human urine using fractional factorial design.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Gas Chromatography-Mass Spectrometry; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Substance Abuse Detection | 2008 |
Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons.
Topics: Adrenergic Uptake Inhibitors; Amphetamine-Related Disorders; Animals; Animals, Newborn; Dose-Response Relationship, Drug; Drug Resistance; Excitatory Amino Acid Antagonists; Mesencephalon; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Organ Culture Techniques; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Serotonin; Synaptic Transmission; Up-Regulation | 2008 |
Liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethampheta
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain; Brain Chemistry; Chromatography, Liquid; Deoxyepinephrine; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2008 |
Determination of amphetamine, methamphetamine, MDA and MDMA in human hair by GC-EI-MS after derivatization with perfluorooctanoyl chloride.
Topics: Amphetamine; Caprylates; Female; Fluorocarbons; Gas Chromatography-Mass Spectrometry; Hair; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Quality Control; Regression Analysis; Reproducibility of Results; Time Factors | 2009 |
Analysis of amphetamines in urine with liquid-liquid extraction by capillary electrophoresis with simultaneous electrochemical and electrochemiluminescence detection.
Topics: 2,2'-Dipyridyl; 3,4-Methylenedioxyamphetamine; Amphetamines; Electrochemical Techniques; Electrophoresis, Capillary; Female; Humans; Luminescent Measurements; Methamphetamine; Microelectrodes; N-Methyl-3,4-methylenedioxyamphetamine; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Diazatetraester 1H-pyrazole crowns as fluorescent chemosensors for AMPH, METH, MDMA (ecstasy), and dopamine.
Topics: Amphetamine; Aza Compounds; Costs and Cost Analysis; Dopamine; Esters; Fluorescent Dyes; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pyrazoles; Sensitivity and Specificity; Spectrometry, Fluorescence; Time Factors; Titrimetry; Water | 2008 |
Multiclass analysis of illicit drugs in plasma and oral fluids by LC-MS/MS.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Body Fluids; Calibration; Chromatography, High Pressure Liquid; Cocaine; Dronabinol; Humans; Illicit Drugs; Ketamine; Methamphetamine; Morphine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Sensitivity and Specificity; Tandem Mass Spectrometry; Time Factors | 2009 |
A validated gas chromatographic-electron impact ionization mass spectrometric method for methamphetamine, methylenedioxymethamphetamine (MDMA), and metabolites in mouse plasma and brain.
Topics: Animals; Brain Chemistry; Gas Chromatography-Mass Spectrometry; Humans; Hydrolysis; Male; Methamphetamine; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2008 |
Use of and attitudes toward club drugs by medical students.
Topics: Adult; Anesthetics, Intravenous; Anti-Anxiety Agents; Central Nervous System Stimulants; Dextromethorphan; Excitatory Amino Acid Antagonists; Female; Flunitrazepam; Hallucinogens; Health Knowledge, Attitudes, Practice; Humans; Illicit Drugs; Ketamine; Lysergic Acid Diethylamide; Male; Methamphetamine; Midwestern United States; N-Methyl-3,4-methylenedioxyamphetamine; Sex Distribution; Sodium Oxybate; Students, Medical; Substance-Related Disorders; Surveys and Questionnaires; Young Adult | 2008 |
Simultaneous determination of methamphetamine, 3,4-methylenedioxy-N-methylamphetamine, 3,4-methylenedioxy-N-ethylamphetamine, N,N-dimethylamphetamine, and their metabolites in urine by liquid chromatography-electrospray ionization-tandem mass spectrometry
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Chromatography, High Pressure Liquid; Humans; Hydrogen-Ion Concentration; Indicators and Reagents; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2008 |
Simultaneous liquid chromatographic-electrospray ionization mass spectrometric quantification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its metabolites 3,4-dihydroxymethamphetamine, 4-hydroxy-3-methoxymethamphetamine and 3,4-methylenedioxya
Topics: 3,4-Methylenedioxyamphetamine; Animals; Chromatography, Liquid; Deoxyepinephrine; Forensic Toxicology; Hallucinogens; Humans; Hydrolysis; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Saimiri; Spectrometry, Mass, Electrospray Ionization | 2009 |
Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Discrimination Learning; DOM 2,5-Dimethoxy-4-Methylamphetamine; Hallucinogens; Lysergic Acid Diethylamide; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; N,N-Dimethyltryptamine; Rats; Rats, Sprague-Dawley | 2009 |
Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates.
Topics: Analysis of Variance; Animals; Behavior, Animal; Brain; Central Nervous System Stimulants; Conditioning, Operant; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Interactions; Electrochemical Techniques; Female; Fluorine Radioisotopes; Fluorobenzenes; Hallucinogens; Macaca mulatta; Magnetic Resonance Spectroscopy; Male; Methamphetamine; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Nortropanes; Piperidines; Positron-Emission Tomography; Reinforcement Schedule; Saimiri; Serotonin Antagonists; Tropanes | 2009 |
Inhibitory effect of selective serotonin reuptake inhibitors on the vesicular monoamine transporter 2.
Topics: Animals; Dopamine; Fluoxetine; Fluvoxamine; Haloperidol; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Rats; Rats, Wistar; Reserpine; Selective Serotonin Reuptake Inhibitors; Synaptic Vesicles; Vesicular Monoamine Transport Proteins | 2009 |
Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry.
Topics: Animals; Baclofen; Benzazepines; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Flumazenil; Hypothermia; Illicit Drugs; Male; Methamphetamine; Morpholines; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Naltrexone; Rats; Rats, Wistar; Ritanserin; Sodium Oxybate; Telemetry | 2009 |
Sildenafil (Viagra) and club drug use in gay and bisexual men: the role of drug combinations and context.
Topics: Bisexuality; Cocaine; Drug Combinations; Homosexuality, Male; Humans; Illicit Drugs; Ketamine; Leisure Activities; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Purines; Sildenafil Citrate; Sodium Oxybate; Substance-Related Disorders; Sulfones | 2007 |
Repeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain.
Topics: Adrenergic Uptake Inhibitors; Animals; Blotting, Western; Brain; Dopamine; Drug Tolerance; Fever; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neuroprotective Agents; Rats; RNA-Binding Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin | 2009 |
The spatial epidemiology of cocaine, methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) use: a demonstration using a population measure of community drug load derived from municipal wastewater.
Topics: Cocaine; Environmental Monitoring; Epidemiological Monitoring; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Oregon; Rural Population; Substance Abuse Detection; Substance-Related Disorders; Urban Population; Waste Disposal, Fluid; Water Pollutants, Chemical | 2009 |
The role of human UDP-glucuronyltransferases on the formation of the methylenedioxymethamphetamine (ecstasy) phase II metabolites R- and S-3-methoxymethamphetamine 4-O-glucuronides.
Topics: Animals; Glucuronides; Glucuronosyltransferase; Humans; Isoenzymes; Male; Methamphetamine; Microsomes, Liver; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar | 2009 |
Crystal structures of a therapeutic single chain antibody in complex with two drugs of abuse-Methamphetamine and 3,4-methylenedioxymethamphetamine.
Topics: Amino Acid Sequence; Antibodies, Monoclonal; Binding Sites, Antibody; Hydrophobic and Hydrophilic Interactions; Illicit Drugs; Immunoglobulin Variable Region; Methamphetamine; Models, Molecular; Molecular Sequence Data; N-Methyl-3,4-methylenedioxyamphetamine; Nuclear Magnetic Resonance, Biomolecular; Protein Binding; Water | 2009 |
Effects of MDMA, methamphetamine and methylphenidate on repeated acquisition and performance in rats.
Topics: Animals; Dose-Response Relationship, Drug; Male; Methamphetamine; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reaction Time; Reinforcement Schedule; Time Factors | 2009 |
Methamphetamine- and 3,4-methylenedioxymethamphetamine-induced behavioral changes in histamine H3-receptor knockout mice.
Topics: Alleles; Animals; Behavior, Animal; Crosses, Genetic; Heterozygote; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Mutation; N-Methyl-3,4-methylenedioxyamphetamine; Receptors, Histamine H3; Spatial Behavior | 2009 |
[Amphetamine and its analogues determination in urine from patients hospitalized in the Department of Toxicology Jagiellonian University Collegium Medicum in Krakow].
Topics: Amphetamine; Amphetamine-Related Disorders; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Poland; Substance Abuse Detection | 2009 |
Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans.
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Female; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Young Adult | 2009 |
Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in rats.
Topics: Animals; Antipsychotic Agents; Benzazepines; Central Nervous System; Cocaine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Salicylamides; Self Administration | 2009 |
Can the severity of dependence scale be usefully applied to 'ecstasy'?
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cross-Sectional Studies; Female; Hallucinogens; Humans; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Risk-Taking; Severity of Illness Index; Young Adult | 2009 |
Ecstasy and methamphetamine elicit action potential bursts via different mechanisms in a central snail neuron.
Topics: Action Potentials; Adrenergic Agents; Animals; Biophysics; Calcium; Colforsin; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Enzyme Inhibitors; Ganglia, Invertebrate; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Patch-Clamp Techniques; Phorbol 12,13-Dibutyrate; Potassium Channel Blockers; Snails; Tetraethylammonium | 2010 |
Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
Topics: 5,7-Dihydroxytryptamine; Animals; Area Under Curve; Benzylamines; Brain; Central Nervous System Stimulants; Disease Models, Animal; Female; Gene Expression; Hallucinogens; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Neurotransmitter Uptake Inhibitors; Pregnancy; Protein Binding; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins; Synaptosomes; Time Factors; Vesicular Monoamine Transport Proteins | 2010 |
Brain serotonin, psychoactive drugs, and effects on reproduction.
Topics: Affect; Amphetamine-Related Disorders; Animals; Biological Clocks; Brain; Cognition Disorders; Depressive Disorder; Drug Interactions; Female; Fenfluramine; Fluoxetine; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Obesity; Psychotropic Drugs; Reproduction; Serotonin; Serotonin Receptor Agonists; Sexual Behavior, Animal; Substance-Related Disorders; Synaptic Transmission | 2009 |
Brain temperature homeostasis: physiological fluctuations and pathological shifts.
Topics: Adrenergic Uptake Inhibitors; Animals; Blood-Brain Barrier; Body Temperature; Brain; Brain Diseases; Central Nervous System Stimulants; Cerebrovascular Circulation; Homeostasis; Humans; Hydroxylamines; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats | 2010 |
Rapid and simple determination of psychotropic phenylalkylamine derivatives in human hair by gas chromatography-mass spectrometry using micro-pulverized extraction.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Hair; Hallucinogens; Humans; Ketamine; Limit of Detection; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection | 2010 |
Identification and quantitation of amphetamine, methamphetamine, MDMA, pseudoephedrine, and ephedrine in blood, plasma, and serum using gas chromatography-mass spectrometry (GC/MS).
Topics: Amphetamine; Ephedrine; Gas Chromatography-Mass Spectrometry; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pseudoephedrine; Reproducibility of Results | 2010 |
Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice.
Topics: Animals; Body Temperature Regulation; Cell Line; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Humans; Macaca mulatta; Male; Methamphetamine; Mice; Mice, Knockout; N-Methyl-3,4-methylenedioxyamphetamine; Phenethylamines; Receptors, G-Protein-Coupled; Serotonin; Synaptosomes; Thyroid Hormones; Thyronines | 2010 |
Gas chromatography-ion trap mass spectrometry method for the simultaneous measurement of MDMA (ecstasy) and its metabolites, MDA, HMA, and HMMA in plasma and urine.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Dopamine; Gas Chromatography-Mass Spectrometry; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Sensitivity and Specificity | 2010 |
Factor structure of the Chinese version of the University of Rhode Island change assessment in Taiwanese adolescents who abuse MDMA or methamphetamine.
Topics: Adolescent; Adolescent Behavior; Asian People; Attitude to Health; Factor Analysis, Statistical; Female; Humans; Male; Methamphetamine; Motivation; N-Methyl-3,4-methylenedioxyamphetamine; Psychiatric Status Rating Scales; Substance-Related Disorders; Surveys and Questionnaires; Taiwan | 2010 |
Detection of Delta9-tetrahydrocannabinol and amphetamine-type stimulants in oral fluid using the Rapid Stat point-of-collection drug-testing device.
Topics: Amphetamine; Amphetamine-Related Disorders; Amphetamines; Dronabinol; False Negative Reactions; False Positive Reactions; Gas Chromatography-Mass Spectrometry; Humans; Immunoassay; Marijuana Abuse; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Predictive Value of Tests; Saliva; Sensitivity and Specificity; Solid Phase Extraction; Substance Abuse Detection | 2010 |
Performance evaluation of the DrugWipe® 5/5+ on-site oral fluid screening device.
Topics: Adolescent; Adult; Amphetamines; Cocaine; Dronabinol; Female; Finland; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Police; Predictive Value of Tests; Saliva; Substance Abuse Detection; Young Adult | 2011 |
Illicit drugs in Canadian municipal wastewater and estimates of community drug use.
Topics: Amphetamine; Canada; Cities; Cocaine; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Solid Phase Extraction; Substance Abuse Detection; Substance-Related Disorders; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Pollution, Chemical | 2010 |
Simultaneous quantification of amphetamines, caffeine and ketamine in urine by hollow fiber liquid phase microextraction combined with gas chromatography-flame ionization detector.
Topics: Amphetamines; Caffeine; Calibration; Chromatography, Gas; Drug Monitoring; Flame Ionization; Humans; Ketamine; Limit of Detection; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Substance-Related Disorders | 2010 |
Twenty-three deaths with gamma-hydroxybutyrate overdose in western Sweden between 2000 and 2007.
Topics: Adolescent; Adult; Central Nervous System Stimulants; Cocaine; Drug Overdose; Female; Hallucinogens; Heroin; Humans; Immunoassay; Male; Marijuana Abuse; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Prescription Drugs; Retrospective Studies; Sodium Oxybate; Substance-Related Disorders; Sweden; Young Adult | 2010 |
Comparison of (+)-methamphetamine, ±-methylenedioxymethamphetamine, (+)-amphetamine and ±-fenfluramine in rats on egocentric learning in the Cincinnati water maze.
Topics: Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Body Temperature; Body Weight; Central Nervous System Stimulants; Cold Temperature; Fenfluramine; Male; Maze Learning; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin Agents; Spatial Behavior; Swimming; Time Factors | 2011 |
Effects of motivational enhancement therapy on readiness to change MDMA and methamphetamine use behaviors in Taiwanese adolescents.
Topics: Adolescent; Amphetamine-Related Disorders; Behavior Therapy; Female; Humans; Male; Methamphetamine; Motivation; N-Methyl-3,4-methylenedioxyamphetamine; Psychotherapy, Brief; Surveys and Questionnaires; Taiwan; Treatment Outcome | 2011 |
Instability of the ecstasy market and a new kid on the block: mephedrone.
Topics: Amphetamine; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Netherlands; Tablets | 2011 |
Behavioral profiles in rats distinguish among "ecstasy," methamphetamine and 2,5-dimethoxy-4-iodoamphetamine: Mixed effects for "ecstasy" analogues.
Topics: Amphetamines; Animals; Avoidance Learning; Behavior, Animal; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Hallucinogens; Male; Maze Learning; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley | 2010 |
Detection of phentermine in hair samples from drug suspects.
Topics: Adult; Amphetamine; Central Nervous System Stimulants; Female; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Hair; Humans; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Phentermine; Substance Abuse Detection; Substance-Related Disorders | 2011 |
Differences in binding affinities of MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their deuterated analogues to solid-phase extraction cartridges.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Deuterium; Gas Chromatography-Mass Spectrometry; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Solid Phase Extraction; Substance Abuse Detection | 2011 |
A case of extreme agitation and death after the use of mephedrone in The Netherlands.
Topics: Adult; Brain Edema; Central Nervous System Stimulants; Cocaine; Contusions; Delirium; Designer Drugs; Forensic Toxicology; Gastrointestinal Contents; Hemorrhage; Humans; Lacerations; Male; Methamphetamine; Midazolam; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Netherlands; Oxazepam; Rage; Skin | 2011 |
Urine analysis of 3,4-methylenedioxypyrovalerone in opioid-dependent patients by gas chromatography-mass spectrometry.
Topics: Adult; Amphetamine; Benzodioxoles; Designer Drugs; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Opiate Substitution Treatment; Opioid-Related Disorders; Psychotropic Drugs; Pyrrolidines; Substance Abuse Detection; Synthetic Cathinone | 2011 |
Sewage epidemiology--a real-time approach to estimate the consumption of illicit drugs in Brussels, Belgium.
Topics: Belgium; Biological Oxygen Demand Analysis; Cocaine; Demography; Heroin; Humans; Illicit Drugs; Methadone; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nitrogen; Phosphorus; Sewage; Substance Abuse Detection; Substance-Related Disorders; Water Pollutants, Chemical; Water Pollution, Chemical | 2011 |
Sulfation of the 3,4-methylenedioxymethamphetamine (MDMA) metabolites 3,4-dihydroxymethamphetamine (DHMA) and 4-hydroxy-3-methoxymethamphetamine (HMMA) and their capability to inhibit human sulfotransferases.
Topics: Cytosol; Dopamine; Hallucinogens; Humans; Kinetics; Mandelic Acids; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Sulfotransferases | 2011 |
Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
Topics: Analysis of Variance; Animals; Body Temperature; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Immunohistochemistry; Methamphetamine; Mice; Mice, Knockout; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Neurotoxicity Syndromes; Receptors, Dopamine D2; Tyrosine 3-Monooxygenase | 2011 |
Determination of amphetamine-type stimulants, cocaine and ketamine in human hair by liquid chromatography/linear ion trap-Orbitrap hybrid mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Chromatography, Liquid; Cocaine; Hair; Humans; Illicit Drugs; Ketamine; Limit of Detection; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Tandem Mass Spectrometry | 2011 |
Drug profiling: a new scientific contribution to law enforcement operations in Viet Nam.
Topics: Alkaloids; Commerce; Counterfeit Drugs; Developing Countries; Drug and Narcotic Control; Drug Contamination; Forensic Sciences; Gas Chromatography-Mass Spectrometry; Heroin; Humans; Illicit Drugs; Law Enforcement; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Vietnam | 2005 |
The prevalence of drugs in injured drivers.
Topics: Accidents, Traffic; Alcohol Drinking; Australia; Automobile Driving; Central Nervous System Depressants; Dronabinol; Enzyme-Linked Immunosorbent Assay; Ethanol; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pharmaceutical Preparations; Psychotropic Drugs; Substance Abuse Detection | 2012 |
Population drug use in Australia: a wastewater analysis.
Topics: Australia; Cocaine; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Sewage; Substance-Related Disorders; Suburban Population; Time Factors; Urban Population | 2011 |
A web-based survey on mephedrone.
Topics: Adolescent; Adult; Aged; Central Nervous System Stimulants; Cocaine; Commerce; Data Collection; Designer Drugs; Drug Users; Female; Humans; Illicit Drugs; Internet; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Young Adult | 2011 |
Simultaneous determination of HFBA-derivatized amphetamines and ketamines in urine by gas chromatography-mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Fluorocarbons; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; Ketamine; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Solid Phase Extraction; Substance Abuse Detection | 2011 |
Pharmacodynamic interactions between MDMA and concomitants in MDMA tablets on extracellular dopamine and serotonin in the rat brain.
Topics: Animals; Brain; Caffeine; Dopamine; Drug Interactions; Extracellular Space; Ketamine; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Serotonin; Tablets | 2011 |
[Simple and rapid screening for methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) and their metabolites in urine using direct analysis in real time (DART)-TOFMS].
Topics: Humans; Mass Spectrometry; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection | 2011 |
Recent trends in pharmaceutical drug use among frequent injecting drug users, frequent methamphetamine users and frequent ecstasy users in New Zealand, 2006-2009.
Topics: Adult; Amphetamine-Related Disorders; Female; Humans; Illicit Drugs; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; New Zealand; Prescription Drugs; Substance Abuse Detection; Substance Abuse, Intravenous; Substance-Related Disorders; Surveys and Questionnaires; Young Adult | 2011 |
Synthesis and neurotoxicity profile of 2,4,5-trihydroxymethamphetamine and its 6-(N-acetylcystein-S-yl) conjugate.
Topics: Acetylcysteine; Adrenergic Uptake Inhibitors; Animals; Brain; Hydroxyindoleacetic Acid; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Neurotoxins; Rats; Rats, Sprague-Dawley; Serotonin | 2011 |
A Caenorhabditis elegans p38 MAP kinase pathway mutant protects from dopamine, methamphetamine, and MDMA toxicity.
Topics: Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Dopamine; Dopamine Agents; Immunity, Innate; Methamphetamine; Mutation; N-Methyl-3,4-methylenedioxyamphetamine; p38 Mitogen-Activated Protein Kinases; Parkinson Disease; Protein Serine-Threonine Kinases; Serotonin Agents; Signal Transduction | 2011 |
Influences of activity wheel access on the body temperature response to MDMA and methamphetamine.
Topics: Animals; Behavior, Animal; Body Temperature; Dose-Response Relationship, Drug; Fever; Male; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar | 2011 |
Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Chromatography, High Pressure Liquid; Dopamine; Hydroxyindoleacetic Acid; Locomotion; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Serotonin | 2011 |
Development and validation of LC-HRMS and GC-NICI-MS methods for stereoselective determination of MDMA and its phase I and II metabolites in human urine.
Topics: Chromatography, Liquid; Deoxyepinephrine; Drug Stability; Gas Chromatography-Mass Spectrometry; Glucuronides; Humans; Least-Squares Analysis; Mass Spectrometry; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism; Sulfates | 2011 |
A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans.
Topics: Administration, Oral; Adult; Cognition; Eating; Female; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Psychomotor Performance; Sleep; Young Adult | 2012 |
Modulation of human GABAA receptor function: a novel mode of action of drugs of abuse.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Binding, Competitive; Dose-Response Relationship, Drug; GABA Modulators; gamma-Aminobutyric Acid; Humans; Illicit Drugs; Membrane Potentials; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Oocytes; Patch-Clamp Techniques; Piperazines; Receptors, GABA-A; Time Factors; Xenopus laevis | 2011 |
Refining the estimation of illicit drug consumptions from wastewater analysis: co-analysis of prescription pharmaceuticals and uncertainty assessment.
Topics: Chromatography, Liquid; Cocaine; Environmental Monitoring; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pharmaceutical Preparations; Sewage; Substance Abuse Detection; Tandem Mass Spectrometry; Waste Disposal, Fluid; Water Pollutants, Chemical | 2011 |
Investigation on the enantioselectivity of the sulfation of the methylenedioxymethamphetamine metabolites 3,4-dihydroxymethamphetamine and 4-hydroxy-3-methoxymethamphetamine using the substrate-depletion approach.
Topics: Chromatography, Gas; Chromatography, Liquid; Humans; Isoenzymes; Kinetics; Lactates; Mandelic Acids; Mass Spectrometry; Metabolic Detoxication, Phase I; Metabolic Detoxication, Phase II; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Sulfates; Sulfotransferases | 2011 |
Marked decline in 3,4-methylenedioxymethamphetamine (MDMA) based on wastewater analysis.
Topics: Australia; Chromatography, High Pressure Liquid; Cocaine; Cross-Sectional Studies; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Population Surveillance; Saliva; Solid Phase Extraction; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry; Urban Health; Waste Disposal, Fluid; Water Supply | 2011 |
Effectiveness of and challenges faced by surveillance systems.
Topics: Australia; Cocaine; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Population Surveillance; Substance-Related Disorders | 2011 |
Antidepressant-like effects of 3,4-methylenedioxymethamphetamine in an animal model of depression.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Brain; Central Nervous System Stimulants; Depressive Disorder; Disease Models, Animal; Hydroxyindoleacetic Acid; Male; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin; Swimming | 2011 |
Effects of exposure to amphetamine derivatives on passive avoidance performance and the central levels of monoamines and their metabolites in mice: correlations between behavior and neurochemistry.
Topics: Adrenergic Agents; Animals; Avoidance Learning; Behavior, Animal; Brain; Chromatography, High Pressure Liquid; Dopamine; Dose-Response Relationship, Drug; Linear Models; Male; Memory; Methamphetamine; Mice; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine; Serotonin; Serotonin Agents | 2012 |
Methamphetamine, amphetamine, MDMA ('ecstasy'), MDA and mCPP modulate electrical and cholinergic input in PC12 cells.
Topics: 3,4-Methylenedioxyamphetamine; Adrenergic Agents; Amphetamine; Animals; Calcium; Cholinergic Agents; Dose-Response Relationship, Drug; Membrane Potentials; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; PC12 Cells; Piperazines; Potassium Chloride; Rats; Serotonin Receptor Agonists | 2012 |
[Paramethoxymethamphetamine].
Topics: Arrhythmias, Cardiac; Central Nervous System Stimulants; Hallucinogens; Humans; Illicit Drugs; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Seizures | 2011 |
Lethal serotonin syndrome after methylone and butylone ingestion.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Fatal Outcome; Female; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Serotonin Syndrome; Young Adult | 2012 |
The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue.
Topics: 1-Methyl-4-phenylpyridinium; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Electrochemistry; Hallucinogens; In Vitro Techniques; Locomotion; Male; Membrane Transport Proteins; Methamphetamine; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine Plasma Membrane Transport Proteins; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Serotonin; Synaptosomes; Time Factors; Tritium | 2012 |
Interaction of 3,4-methylenedioxymethamphetamine and methamphetamine during metabolism by in vitro human metabolic enzymes and in rats.
Topics: Animals; Biotransformation; Cytochrome P-450 CYP2D6; Cytosol; Drug Interactions; Forensic Toxicology; Hallucinogens; Humans; In Vitro Techniques; Male; Methamphetamine; Microsomes; Monoamine Oxidase; N-Methyl-3,4-methylenedioxyamphetamine; Oxygenases; Rats; Rats, Wistar | 2012 |
[A new designer drug: methylone related death].
Topics: Adolescent; Amphetamine; Asthma; Autopsy; Causality; Death, Sudden, Cardiac; Designer Drugs; Drug Overdose; Fatal Outcome; Fatty Liver; Heart Defects, Congenital; Humans; Hungary; Male; Methamphetamine; Muscle, Smooth; N-Methyl-3,4-methylenedioxyamphetamine | 2012 |
Estimation of community-wide drugs use via stereoselective profiling of sewage.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; England; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Prescription Drugs; Sewage; Stereoisomerism; Substance Abuse Detection; Substance-Related Disorders | 2012 |
Development of a simultaneous analytical method for selected anorectics, methamphetamine, MDMA, and their metabolites in hair using LC-MS/MS to prove anorectics abuse.
Topics: Amphetamines; Appetite Depressants; Chromatography, Liquid; Hair; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Tandem Mass Spectrometry | 2012 |
[The phenomenon of drug change in the interviews with injecting drug users].
Topics: Adolescent; Adult; Amphetamine; Cocaine; Cocaine-Related Disorders; Designer Drugs; Dopamine Uptake Inhibitors; Drug Users; Female; Heroin; Humans; Hungary; Illicit Drugs; Interview, Psychological; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Narration; Needle-Exchange Programs; Risk-Taking; Substance Abuse, Intravenous; Young Adult | 2012 |
Prospective associations between meth/amphetamine (speed) and MDMA (ecstasy) use and depressive symptoms in secondary school students.
Topics: Adolescent; Amphetamine-Related Disorders; Central Nervous System Stimulants; Depression; Female; Humans; Illicit Drugs; Logistic Models; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Prospective Studies; Quebec; Socioeconomic Factors; Students | 2012 |
Evaluation of hair roots for detection of methamphetamine and 3,4-methylenedioxymethamphetamine abuse by use of an HPLC-chemiluminescence method.
Topics: Animals; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Equipment Design; Hair; Luminescent Measurements; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Sensitivity and Specificity; Substance Abuse Detection | 2012 |
Differential effects of modafinil, methamphetamine, and MDMA on agonistic behavior in male mice.
Topics: Aggression; Animals; Behavior, Animal; Benzhydryl Compounds; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Male; Methamphetamine; Mice; Modafinil; N-Methyl-3,4-methylenedioxyamphetamine | 2012 |
The impact of comorbid cannabis and methamphetamine use on mental health among regular ecstasy users.
Topics: Adult; Aged; Amphetamine-Related Disorders; Cross-Sectional Studies; Female; Health Status; Humans; Male; Marijuana Abuse; Mental Health; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Psychiatric Status Rating Scales; Risk Factors; Self Report; Stress, Psychological; Young Adult | 2012 |
Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats.
Topics: Animals; Benzodioxoles; Central Nervous System Stimulants; Data Interpretation, Statistical; Designer Drugs; Dextroamphetamine; Dose-Response Relationship, Drug; Hallucinogens; Male; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Pyrrolidines; Rats; Rats, Wistar; Stimulation, Chemical; Synthetic Cathinone | 2012 |
Molecularly imprinted-solid phase extraction combined with simultaneous derivatization and dispersive liquid-liquid microextraction for selective extraction and preconcentration of methamphetamine and ecstasy from urine samples followed by gas chromatogra
Topics: Calibration; Central Nervous System Agents; Chromatography, Gas; Flame Ionization; Humans; Limit of Detection; Liquid Phase Microextraction; Methamphetamine; Molecular Imprinting; N-Methyl-3,4-methylenedioxyamphetamine; Solid Phase Extraction; Substance Abuse Detection | 2012 |
Drugs of abuse in wastewater and suspended particulate matter--further developments in sewage epidemiology.
Topics: Cocaine; Czech Republic; Environmental Monitoring; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pyrrolidines; Sewage; Substance-Related Disorders; Wastewater; Water Pollutants, Chemical; Water Pollution, Chemical | 2012 |
Motor cortex and corticospinal excitability in humans with a history of illicit stimulant use.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Electromyography; Evoked Potentials, Auditory, Brain Stem; Female; Humans; Male; Marijuana Abuse; Methamphetamine; Middle Aged; Motor Cortex; N-Methyl-3,4-methylenedioxyamphetamine; Pyramidal Tracts; Substance-Related Disorders; Transcranial Magnetic Stimulation; Young Adult | 2012 |
The risky cocktail: what combination effects can we expect between ecstasy and other amphetamines?
Topics: Amphetamines; Cell Line; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Humans; Illicit Drugs; Methamphetamine; Models, Theoretical; N-Methyl-3,4-methylenedioxyamphetamine; Regression Analysis | 2013 |
Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone-induced hypothermia.
Topics: Adrenergic Antagonists; Alkaloids; Animals; Body Temperature; Body Temperature Regulation; Brain; Catecholamines; Dopamine Antagonists; Hypothermia; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Regional Blood Flow | 2013 |
Evaluation of pre-analysis loss of dependent drugs in wastewater: stability and binding assessments.
Topics: Amphetamine; Chromatography, Liquid; Cocaine; Codeine; Cotinine; Drug Stability; Illicit Drugs; Liquid-Liquid Extraction; Methamphetamine; Morphine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2013 |
Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat.
Topics: Alkaloids; Animals; Brain; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Random Allocation; Rats | 2013 |
Discriminative stimulus effects of N,N-diisopropyltryptamine.
Topics: Animals; Discrimination Learning; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dose-Response Relationship, Drug; Hallucinogens; Lysergic Acid Diethylamide; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Tryptamines | 2013 |
Do prenatally methamphetamine-exposed adult male rats display general predisposition to drug abuse in the conditioned place preference test?
Topics: Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Psychological; Disease Susceptibility; Female; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Substance-Related Disorders | 2012 |
Behavioral and antinociceptive effects of different psychostimulant drugs in prenatally methamphetamine-exposed rats.
Topics: Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Cocaine; Female; Male; Methamphetamine; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Pregnancy; Prenatal Exposure Delayed Effects; Rats | 2012 |
Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA.
Topics: Amphetamine; Animals; Corpus Striatum; Dopamine; Drug Synergism; Female; Fever; Methamphetamine; Mice; Mice, Inbred C57BL; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Endings; Psychotropic Drugs | 2013 |
Circumstances of initiation into new-type drug use among adults in Shanghai: are there differences by types of first new-type drug used?
Topics: Adolescent; Adult; China; Drug Users; Female; Humans; Illicit Drugs; Ketamine; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders; Young Adult | 2013 |
Warning against co-administration of 3,4-methylenedioxymethamphetamine (MDMA) with methamphetamine from the perspective of pharmacokinetic and pharmacodynamic evaluations in rat brain.
Topics: Animals; Brain; Injections, Intraperitoneal; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar | 2013 |
Illicit stimulant use is associated with abnormal substantia nigra morphology in humans.
Topics: Adolescent; Adult; Central Nervous System Stimulants; Cocaine; Drug Users; Humans; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Substantia Nigra; Surveys and Questionnaires; Ultrasonography, Doppler, Transcranial; Young Adult | 2013 |
Do novel psychoactive substances displace established club drugs, supplement them or act as drugs of initiation? The relationship between mephedrone, ecstasy and cocaine.
Topics: Adult; Cocaine; Data Collection; Drug Users; Female; Humans; Illicit Drugs; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Psychotropic Drugs | 2013 |
Concentrations of drugs determined in blood samples collected from suspected drugged drivers in England and Wales.
Topics: Adolescent; Adult; Amphetamine; Automobile Driving; Central Nervous System Depressants; Chromatography, Liquid; Cocaine; Diazepam; England; Ethanol; Female; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Ketamine; Male; Methadone; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Nordazepam; Sodium Oxybate; Substance Abuse Detection; Substance-Related Disorders; Wales; Young Adult | 2013 |
Identification of an allosteric modulator of the serotonin transporter with novel mechanism of action.
Topics: Allosteric Regulation; Animals; Binding Sites; Chlorocebus aethiops; Computer Simulation; COS Cells; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Humans; Methamphetamine; Models, Molecular; Mutagenesis; N-Methyl-3,4-methylenedioxyamphetamine; Protein Binding; Protein Structure, Tertiary; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Transfection; Tritium | 2013 |
Direct analyte-probed nanoextraction coupled to nanospray ionization-mass spectrometry of drug residues from latent fingerprints.
Topics: Caffeine; Central Nervous System Stimulants; Cocaine; Dermatoglyphics; Heroin; Humans; Mass Spectrometry; Methamphetamine; Microscopy; N-Methyl-3,4-methylenedioxyamphetamine; Nanotechnology; Narcotics; Sebum; Spectrum Analysis, Raman; Sweat | 2013 |
Combination effects of amphetamines under hyperthermia - the role played by oxidative stress.
Topics: Adenosine Triphosphate; Amphetamines; Cell Survival; Dextroamphetamine; Dose-Response Relationship, Drug; Energy Metabolism; Glutathione; Hep G2 Cells; Hepatocytes; Humans; Hyperthermia, Induced; Lipid Peroxidation; Methamphetamine; Mitochondria, Liver; Mitochondrial Membranes; N-Methyl-3,4-methylenedioxyamphetamine; Oxidative Stress; Reactive Nitrogen Species; Reactive Oxygen Species; Risk Assessment | 2014 |
A field test of substance use screening devices as part of routine drunk-driving spot detection operating procedures in South Africa.
Topics: Adolescent; Adult; Alcohol Drinking; Alcoholic Intoxication; Amphetamine; Automobile Driving; Breath Tests; Chromatography, Liquid; Cocaine; Dronabinol; Ethanol; Female; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; Male; Mass Spectrometry; Methamphetamine; Middle Aged; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Pilot Projects; Saliva; South Africa; Substance Abuse Detection; Young Adult | 2013 |
Stability of 3,4-methylenedioxymethampetamine (MDMA), 4-methylmethcathinone (mephedrone) and 3-trifluromethylphenylpiperazine (3-TFMPP) in formalin solution.
Topics: Calibration; Chromatography, High Pressure Liquid; Designer Drugs; Drug Stability; Formaldehyde; Hallucinogens; Hydrogen-Ion Concentration; Indicators and Reagents; Mass Spectrometry; Methamphetamine; Methylation; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Quality Control; Reference Standards; Reproducibility of Results; Serotonin Receptor Agonists; Solutions | 2013 |
Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus.
Topics: Animals; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Designer Drugs; Female; Hippocampus; Methamphetamine; Mice; Mice, Inbred C57BL; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Endings; Neurotoxicity Syndromes; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tryptophan Hydroxylase | 2014 |
The association between tramadol hydrochloride misuse and other substances use in an adolescent population: Phase I of a prospective survey.
Topics: Adolescent; Alcohol Drinking; Amphetamine-Related Disorders; Analgesics, Opioid; Female; Humans; Iran; Male; Marijuana Smoking; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Odds Ratio; Opioid-Related Disorders; Opium; Prescription Drug Misuse; Prevalence; Prospective Studies; Sex Distribution; Substance-Related Disorders; Surveys and Questionnaires; Tramadol | 2014 |
Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Area Under Curve; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin | 2014 |
The recent expansion in the Australian cocaine market: who are the new users and what are the harms?
Topics: Adolescent; Adult; Age Distribution; Australia; Central Nervous System Stimulants; Cocaine-Related Disorders; Cross-Sectional Studies; Data Collection; Female; Humans; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Public Health; Substance Abuse, Intravenous; Substance-Related Disorders; Young Adult | 2013 |
Estimating daily and diurnal variations of illicit drug use in Hong Kong: a pilot study of using wastewater analysis in an Asian metropolitan city.
Topics: Chromatography, Liquid; Cocaine; Hong Kong; Humans; Ketamine; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Pilot Projects; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry; Time Factors; Urban Population; Wastewater | 2013 |
Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.
Topics: 3,4-Methylenedioxyamphetamine; Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiovascular System; Consciousness; Deoxyepinephrine; Dopamine; Dose-Response Relationship, Drug; Hallucinogens; Heart Rate; Male; Metabolic Detoxication, Phase I; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Telemetry; Time Factors | 2014 |
Results of the Queensland 2007-2012 roadside drug testing program: The prevalence of three illicit drugs.
Topics: Accidents, Traffic; Adolescent; Adult; Age Factors; Amphetamine-Related Disorders; Automobile Driving; Cross-Sectional Studies; Female; Humans; Illicit Drugs; Male; Marijuana Abuse; Methamphetamine; Middle Aged; Motor Vehicles; N-Methyl-3,4-methylenedioxyamphetamine; Queensland; Substance Abuse Detection; Young Adult | 2014 |
Club drugs: coming to a patient near you.
Topics: Adolescent; Adult; Female; Flunitrazepam; Humans; Illicit Drugs; Ketamine; Lysergic Acid Diethylamide; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nurse Practitioners; Primary Care Nursing; Sodium Oxybate; Substance-Related Disorders; Young Adult | 2014 |
Drug use and sexual risk among gay and bisexual men who frequent party venues.
Topics: Adult; Amphetamine-Related Disorders; Bisexuality; Homosexuality, Male; Humans; Ketamine; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Risk Factors; Social Behavior; Sodium Oxybate; Substance-Related Disorders; Unsafe Sex; Young Adult | 2014 |
Adsorption and desorption characteristics of methamphetamine, 3,4-methylenedioxymethamphetamine, and pseudoephedrine in soils.
Topics: Adsorption; Australia; Biodegradation, Environmental; Biological Availability; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pseudoephedrine; Soil; Soil Pollutants; Thermodynamics | 2015 |
Spatial differences and temporal changes in illicit drug use in Europe quantified by wastewater analysis.
Topics: Amphetamines; Cannabinoids; Chromatography, Liquid; Cocaine; Environmental Monitoring; Europe; Humans; Illicit Drugs; Mass Spectrometry; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Population Surveillance; Sewage; Substance Abuse Detection; Substance-Related Disorders; Time Factors; Waste Disposal, Fluid; Water Pollutants, Chemical | 2014 |
Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Cocaine-Related Disorders; Cross-Sectional Studies; Data Collection; Female; Humans; Ketamine; Logistic Models; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Self Report; Substance-Related Disorders; Young Adult | 2015 |
Driving under the influence among frequent ecstasy consumers in Australia: trends over time and the role of risk perceptions.
Topics: Adolescent; Adult; Alcohol Drinking; Australia; Automobile Driving; Central Nervous System Stimulants; Cross-Sectional Studies; Female; Humans; Illicit Drugs; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Perception; Risk-Taking; Substance-Related Disorders; Time Factors; Young Adult | 2014 |
The disruptive effects of methamphetamine on delayed-matching-to-sample performance reflect proactive interference and are reduced by SCH23390.
Topics: Amphetamine-Related Disorders; Animals; Benzazepines; Central Nervous System Stimulants; Disease Models, Animal; Dopamine Antagonists; Male; Memory Disorders; Memory, Short-Term; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 2015 |
Illnesses and deaths among persons attending an electronic dance-music festival - New York City, 2013.
Topics: Adolescent; Adult; Alcohol Drinking; Cocaine; Dancing; Emergency Service, Hospital; Female; Holidays; Humans; Illicit Drugs; Male; Methamphetamine; Music; N-Methyl-3,4-methylenedioxyamphetamine; New York City; Substance-Related Disorders; Young Adult | 2014 |
Hand function is altered in individuals with a history of illicit stimulant use.
Topics: Adolescent; Adult; Cannabis; Female; Hand; Hand Strength; Humans; Illicit Drugs; Lifting; Male; Methamphetamine; Middle Aged; Motor Skills; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Young Adult | 2014 |
Intravenous self-administration of mephedrone, methylone and MDMA in female rats.
Topics: Administration, Intravenous; Animals; Central Nervous System Stimulants; Conditioning, Operant; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Hallucinogens; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Reinforcement Schedule; Self Administration; Time Factors | 2015 |
Forensic toxicological analyses of drugs in tissues in formalin solutions and in fixatives.
Topics: Adult; Antipsychotic Agents; Bromazepam; Chlorpromazine; Cyclopropanes; Drug Stability; Fixatives; Forensic Toxicology; Formaldehyde; Gas Chromatography-Mass Spectrometry; Humans; Kidney; Liver; Male; Methamphetamine; Methotrimeprazine; Milnacipran; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Organ Preservation; Promethazine; Time Factors | 2015 |
The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
Topics: Cell Line, Tumor; Dopamine Plasma Membrane Transport Proteins; HEK293 Cells; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine Plasma Membrane Transport Proteins; Serotonin Plasma Membrane Transport Proteins; Synaptic Vesicles; Vesicular Monoamine Transport Proteins | 2015 |
One day access to a running wheel reduces self-administration of D-methamphetamine, MDMA and methylone.
Topics: Animals; Central Nervous System Stimulants; Drug-Seeking Behavior; Female; Male; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Self Administration | 2015 |
Recreational phenethylamine poisonings reported to a French poison control center.
Topics: Adolescent; Adult; Alkaloids; Amphetamine; Cannabis; Child; Drug Interactions; Ethanol; Female; France; Hospitalization; Humans; Intensive Care Units; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Phenethylamines; Poison Control Centers; Prevalence; Retrospective Studies; Symptom Assessment; Young Adult | 2015 |
Intravenous self-administration of entactogen-class stimulants in male rats.
Topics: Administration, Intravenous; Amphetamine-Related Disorders; Animals; Catheters, Indwelling; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats, Wistar; Self Administration; Sex Characteristics | 2015 |
Significant Misuse of Sildenafil in London Nightclubs.
Topics: Adolescent; Adult; Cocaine; Homosexuality, Male; Humans; Illicit Drugs; London; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Prescription Drug Misuse; Prevalence; Sildenafil Citrate; Substance-Related Disorders; Young Adult | 2015 |
Differential effects of 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone) in rats trained to discriminate MDMA or a d-amphetamine + MDMA mixture.
Topics: Amphetamine; Animals; Benzodioxoles; Central Nervous System Stimulants; Cocaine; Dextroamphetamine; Discrimination Learning; Dose-Response Relationship, Drug; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Synthetic Cathinone | 2016 |
A Retrospective Analysis of Urine Drugs of Abuse Immunoassay True Positive Rates at a National Reference Laboratory.
Topics: Adult; Amphetamine; Chromatography, Liquid; Cocaine; Dronabinol; Ethanol; False Negative Reactions; False Positive Reactions; Female; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; Immunoassay; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Oxycodone; Retrospective Studies; Substance Abuse Detection; Young Adult | 2016 |
Prevention of drug priming- and cue-induced reinstatement of MDMA-seeking behaviors by the CB1 cannabinoid receptor antagonist AM251.
Topics: Amphetamine-Related Disorders; Animals; Cannabinoid Receptor Antagonists; Cues; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Extinction, Psychological; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Pyrazoles; Rats; Self Administration | 2016 |
A study to model the post-mortem stability of 4-MMC, MDMA and BZP in putrefying remains.
Topics: Animals; Forensic Pathology; Illicit Drugs; Methamphetamine; Models, Animal; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Postmortem Changes; Reproducibility of Results; Substance Abuse Detection; Swine | 2016 |
Detection of "bath salts" and other novel psychoactive substances in hair samples of ecstasy/MDMA/"Molly" users.
Topics: Adolescent; Adult; Alkaloids; Animals; Drug Users; Female; Hair; Humans; Illicit Drugs; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; New York City; Self Report; Substance-Related Disorders; Surveys and Questionnaires; Tandem Mass Spectrometry; Young Adult | 2016 |
Do police arrestees substitute legal highs for other drugs?
Topics: Adult; Affect; Amphetamine-Related Disorders; Cannabinoids; Criminals; Drug Users; Female; Harm Reduction; Humans; Illicit Drugs; Interviews as Topic; Male; Marijuana Abuse; Marijuana Smoking; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; New Zealand; Prevalence; Psychotropic Drugs; Time Factors; Young Adult | 2016 |
Ultra-rapid targeted analysis of 40 drugs of abuse in oral fluid by LC-MS/MS using carbon-13 isotopes of methamphetamine and MDMA to reduce detector saturation.
Topics: Carbon Isotopes; Chromatography, Liquid; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Saliva; Tandem Mass Spectrometry | 2016 |
Evaluation of Monitoring Schemes for Wastewater-Based Epidemiology to Identify Drug Use Trends Using Cocaine, Methamphetamine, MDMA and Methadone.
Topics: Cocaine; Methadone; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Wastewater | 2016 |
Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents.
Topics: Animals; Central Nervous System Stimulants; Cocaine; Conditioning, Psychological; Discrimination Learning; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dose-Response Relationship, Drug; Hallucinogens; Indans; Locomotion; Male; Methamphetamine; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley | 2016 |
How various drugs affect anxiety-related behavior in male and female rats prenatally exposed to methamphetamine.
Topics: Analgesics; Analysis of Variance; Animals; Anxiety; Central Nervous System Stimulants; Estrous Cycle; Exploratory Behavior; Female; Male; Maze Learning; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Serotonin Agents; Sex Factors; Time Factors | 2016 |
Determination of amphetamines in hair by integrating sample disruption, clean-up and solid phase derivatization.
Topics: Amphetamine; Amphetamines; Chromatography, Liquid; Ephedrine; Fluorenes; Fluorescent Dyes; Hair; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine | 2016 |
Enantioselective degradation of amphetamine-like environmental micropollutants (amphetamine, methamphetamine, MDMA and MDA) in urban water.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Biodegradation, Environmental; Kinetics; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Photochemical Processes; Rivers; Sewage; Stereoisomerism; Wastewater; Water; Water Microbiology | 2016 |
Caffeine alters the behavioural and body temperature responses to mephedrone without causing long-term neurotoxicity in rats.
Topics: Animals; Behavior, Animal; Body Temperature; Brain; Caffeine; Discrimination, Psychological; Dopamine; Fever; Hypothermia; Illicit Drugs; Locomotion; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Rats; Reflex, Startle; Serotonin | 2016 |
Hematocrit-Independent Quantitation of Stimulants in Dried Blood Spots: Pipet versus Microfluidic-Based Volumetric Sampling Coupled with Automated Flow-Through Desorption and Online Solid Phase Extraction-LC-MS/MS Bioanalysis.
Topics: Adrenergic Agents; Automation; Chromatography, High Pressure Liquid; Dried Blood Spot Testing; Hematocrit; Humans; Methamphetamine; Microfluidics; N-Methyl-3,4-methylenedioxyamphetamine; Phentermine; Solid Phase Extraction; Tandem Mass Spectrometry | 2016 |
Crystalline methamphetamine use and methamphetamine-related harms in Australia.
Topics: Amphetamine-Related Disorders; Australia; Crime; Hospitalization; Hotlines; Humans; Illicit Drugs; Linear Models; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Surveys and Questionnaires | 2017 |
Methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxypyrovalerone (MDPV) induce differential cytotoxic effects in bovine brain microvessel endothelial cells.
Topics: Animals; Benzodioxoles; Blood-Brain Barrier; Cattle; Cell Proliferation; Designer Drugs; Dopamine Agents; Endothelial Cells; Methamphetamine; Microvessels; N-Methyl-3,4-methylenedioxyamphetamine; Necrosis; Nitric Oxide; Pyrrolidines; Reactive Oxygen Species; Serotonin Agents; Synthetic Cathinone | 2016 |
Cocaine, MDMA and methamphetamine residues in wastewater: Consumption trends (2009-2015) in South East Queensland, Australia.
Topics: Cocaine; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Queensland; Rural Population; Substance Abuse Detection; Substance-Related Disorders; Urban Population; Wastewater; Water Pollutants, Chemical | 2016 |
Mephedrone and 3,4-methylenedioxy-methamphetamine: Comparative psychobiological effects as reported by recreational polydrug users.
Topics: Adult; Anger; Anxiety; Cross-Sectional Studies; Female; Humans; Illicit Drugs; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Sleep; Surveys and Questionnaires | 2016 |
Occurrence of illicit drugs and selected pharmaceuticals in Slovak municipal wastewater.
Topics: Cannabinoids; Cities; Cocaine; Environmental Monitoring; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pharmaceutical Preparations; Slovakia; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2016 |
Neurocognitive performance following acute mephedrone administration, with and without alcohol.
Topics: Adult; Attention; Cognition; Cross-Over Studies; Double-Blind Method; Ethanol; Humans; Male; Memory, Short-Term; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Psychomotor Performance; Reaction Time; Young Adult | 2016 |
Identification and characterization of N-tert-butoxycarbonyl-MDMA: a new MDMA precursor.
Topics: Australia; Gas Chromatography-Mass Spectrometry; Hallucinogens; Illicit Drugs; Magnetic Resonance Spectroscopy; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Prodrugs | 2017 |
MDMA, Methylone, and MDPV: Drug-Induced Brain Hyperthermia and Its Modulation by Activity State and Environment.
Topics: Animals; Antipsychotic Agents; Benzodioxoles; Body Temperature; Brain; Carbazoles; Carvedilol; Central Nervous System Stimulants; Clozapine; Environment; Fever; Humans; Interpersonal Relations; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Propanolamines; Pyrrolidines; Rats; Social Behavior; Synthetic Cathinone; Vasoconstriction; Vasodilator Agents | 2017 |
Refining correction factors for back-calculation of illicit drug use.
Topics: Amphetamine; Dronabinol; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Substance Abuse Detection; Wastewater | 2016 |
Decoding the Structure of Abuse Potential for New Psychoactive Substances: Structure-Activity Relationships for Abuse-Related Effects of 4-Substituted Methcathinone Analogs.
Topics: Amphetamine; Animals; Behavior, Animal; Dopamine Plasma Membrane Transport Proteins; Fenfluramine; Humans; Methamphetamine; Methylamines; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine Plasma Membrane Transport Proteins; Propiophenones; Psychotropic Drugs; Quantitative Structure-Activity Relationship; Rats; Self Administration; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Substance-Related Disorders | 2017 |
Comparison of pharmaceutical, illicit drug, alcohol, nicotine and caffeine levels in wastewater with sale, seizure and consumption data for 8 European cities.
Topics: Alcohol Drinking; Amphetamines; Beverages; Caffeine; Central Nervous System Stimulants; Cities; Cocaine; Commerce; Ethanol; Europe; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nicotiana; Nicotine; Pharmaceutical Preparations; Substance Abuse Detection; Substance-Related Disorders; Tobacco Use; Wastewater; Water Pollutants, Chemical | 2016 |
Acute behavioral effects of co-administration of mephedrone and MDMA in mice.
Topics: Animals; Antidepressive Agents; Anxiety; Cognition; Depression; Disease Models, Animal; Drug Interactions; Male; Maze Learning; Memory; Methamphetamine; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Swimming | 2017 |
Simultaneous use of alcohol with methamphetamine but not ecstasy linked with aggression among young adult stimulant users.
Topics: Adult; Aggression; Alcohol Drinking; Australia; Central Nervous System Depressants; Central Nervous System Stimulants; Ethanol; Female; Hallucinogens; Humans; Longitudinal Studies; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Young Adult | 2017 |
The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity.
Topics: Animals; Benzodioxoles; Body Temperature Regulation; Corpus Striatum; Dopamine; Glial Fibrillary Acidic Protein; Gliosis; Male; Methamphetamine; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Pyrrolidines; Synthetic Cathinone; Tyrosine 3-Monooxygenase | 2017 |
Hair Testing for Drugs of Abuse and New Psychoactive Substances in a High-Risk Population.
Topics: Cyclohexanones; Cyclohexylamines; Hair; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pentanones; Prevalence; Psychotropic Drugs; Pyrrolidines; Substance Abuse Detection; Substance-Related Disorders | 2017 |
Sex differences in the strategies of spatial learning in prenatally-exposed rats treated with various drugs in adulthood.
Topics: Animals; Cocaine; Cognition; Dronabinol; Female; Male; Methamphetamine; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Pregnancy; Prenatal Exposure Delayed Effects; Psychological Tests; Psychotropic Drugs; Random Allocation; Rats, Wistar; Sex Characteristics; Spatial Learning; Spatial Navigation | 2017 |
3,4-Methylenedioxymethamphetamine Increases Affiliative Behaviors in Squirrel Monkeys in a Serotonin 2A Receptor-Dependent Manner.
Topics: Animals; Dose-Response Relationship, Drug; Linear Models; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Psychotropic Drugs; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Saimiri; Serotonin Agents; Social Behavior; Vocalization, Animal | 2017 |
Illicit drug consumption in school populations measured by wastewater analysis.
Topics: Amphetamine; Cannabinoids; Cannabis; Cocaine; Humans; Illicit Drugs; Italy; Ketamine; Mass Spectrometry; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Substance-Related Disorders; Wastewater | 2017 |
Dynamic surface-enhanced Raman spectroscopy and Chemometric methods for fast detection and intelligent identification of methamphetamine and 3, 4-Methylenedioxy methamphetamine in human urine.
Topics: Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Principal Component Analysis; Spectrophotometry, Ultraviolet; Spectroscopy, Near-Infrared; Spectrum Analysis, Raman; Substance-Related Disorders; Support Vector Machine | 2018 |
Smoke on the water-Oral fluid analysis at sea.
Topics: Accidents, Occupational; Adolescent; Adult; Australia; Chromatography, Liquid; Dronabinol; Employment; Humans; Illicit Drugs; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Occupations; Saliva; Ships; Substance Abuse Detection; Tandem Mass Spectrometry; Young Adult | 2017 |
Discriminative stimulus and locomotor effects of para-substituted and benzofuran analogs of amphetamine.
Topics: Amphetamine; Amphetamines; Animals; Benzofurans; Central Nervous System Stimulants; Cocaine; Discrimination Learning; Dose-Response Relationship, Drug; Locomotion; Male; Methamphetamine; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley | 2017 |
Commercial herbal medicines used as African traditional medicines: Ngoma Herbal Tonic Immune Booster interferes with a rapid urine drug screening test.
Topics: Amphetamine; Cocaine; Dronabinol; False Negative Reactions; False Positive Reactions; Humans; Medicine, African Traditional; Methamphetamine; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Plant Preparations; Substance Abuse Detection | 2017 |
Intermolecular interactions between DNA and methamphetamine, amphetamine, ecstasy and their major metabolites.
Topics: Amphetamine; Central Nervous System Stimulants; DNA; Humans; Methamphetamine; Molecular Docking Simulation; N-Methyl-3,4-methylenedioxyamphetamine | 2018 |
Wastewater-based epidemiology and enantiomeric profiling for drugs of abuse in South African wastewaters.
Topics: Cocaine; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; South Africa; Substance Abuse Detection; Wastewater; Water Pollutants, Chemical | 2018 |
"Ecstasy" to addiction: Mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA.
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Conditioning, Operant; Disease Models, Animal; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Drug Combinations; Hallucinogens; HEK293 Cells; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Serotonin; Substance-Related Disorders | 2018 |
Patterns of injecting and non-injecting drug use by sexual behaviour in people who inject drugs attending services in England, Wales and Northern Ireland, 2013-2016.
Topics: Adult; Cocaine; England; Female; Heterosexuality; Humans; Illicit Drugs; Ketamine; Male; Methadone; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Northern Ireland; Sexual and Gender Minorities; Sexual Behavior; Solvents; Substance Abuse, Intravenous; Substance-Related Disorders; Wales; Young Adult | 2018 |
Investigating the correlation between wastewater analysis and roadside drug testing in South Australia.
Topics: Cannabinoids; Cannabis; Driving Under the Influence; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Police; Reproducibility of Results; South Australia; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry; Wastewater | 2018 |
New types of drug use and risks of drug use among men who have sex with men: a cross-sectional study in Hangzhou, China.
Topics: Adolescent; Adult; Alcoholism; China; Cross-Sectional Studies; HIV Infections; Homosexuality, Male; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Odds Ratio; Risk Factors; Sexual Behavior; Sexual Partners; Socioeconomic Factors; Substance-Related Disorders | 2018 |
Identification and characterization of 4-chloromethamphetamine (4-CMA) in seized ecstacy - a risk to public health.
Topics: Chromatography, Liquid; Designer Drugs; Gas Chromatography-Mass Spectrometry; Humans; Magnetic Resonance Spectroscopy; Methamphetamine; Molecular Structure; N-Methyl-3,4-methylenedioxyamphetamine | 2018 |
Occurrence, removal and environmental risk of markers of five drugs of abuse in urban wastewater systems in South Australia.
Topics: Biomarkers; Chromatography, Liquid; Cocaine; Environmental Monitoring; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Sewage; Solid Phase Extraction; South Australia; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2019 |
Comparing methamphetamine, MDMA, cocaine, codeine and methadone use between the Auckland region and four Australian states using wastewater-based epidemiology (WBE).
Topics: Australia; Chromatography, Liquid; Cities; Cocaine; Codeine; Humans; Methadone; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; New Zealand; Substance-Related Disorders; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2018 |
3,4-Methylenedioxymethamphetamine, mephedrone, and β-phenylethylamine release dopamine from the cytoplasm by means of transporters and keep the concentration high and constant by blocking reuptake.
Topics: Animals; Calcium; Cytoplasm; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Male; Methamphetamine; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Phenethylamines; Prefrontal Cortex | 2018 |
Stimulant and Designer Drug Use: Primary Care Management.
Topics: Alkaloids; Amphetamine-Related Disorders; Cannabinoids; Central Nervous System Stimulants; Cocaine-Related Disorders; Counseling; Crack Cocaine; Designer Drugs; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Primary Health Care; Psychotropic Drugs | 2018 |
Club Drugs: What You Should Know.
Topics: Anesthetics, Dissociative; Anti-Anxiety Agents; Central Nervous System Stimulants; Flunitrazepam; Hallucinogens; Humans; Illicit Drugs; Ketamine; Lysergic Acid Diethylamide; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine | 2018 |
Determinants of high availability of methamphetamine, cannabis, LSD and ecstasy in New Zealand: Are drug dealers promoting methamphetamine rather than cannabis?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cannabinoids; Cannabis; Female; Humans; Illicit Drugs; Lysergic Acid Diethylamide; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; New Zealand; Substance-Related Disorders; Surveys and Questionnaires; Young Adult | 2018 |
Metabolomics predicts the pharmacological profile of new psychoactive substances.
Topics: Algorithms; Animals; Brain; Cannabinoids; Hallucinogens; Machine Learning; Male; Metabolomics; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Psychotropic Drugs; Rats; Rats, Wistar | 2019 |
Cytotoxicity of new psychoactive substances and other drugs of abuse studied in human HepG2 cells using an adopted high content screening assay.
Topics: Acetaminophen; Alkaloids; Biological Assay; Chromatography, Liquid; Fluorescent Dyes; Fluvastatin; Hep G2 Cells; Hepatocytes; Humans; Illicit Drugs; Indans; Indoles; Membrane Potential, Mitochondrial; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Propranolol; Quinolines; Simvastatin; Tandem Mass Spectrometry; Toxicity Tests | 2019 |
Difference in long-term relapse rates between youths with ketamine use and those with stimulants use.
Topics: Adolescent; Central Nervous System Stimulants; Child; Excitatory Amino Acid Antagonists; Female; Humans; Ketamine; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Recurrence; Risk Factors; Substance-Related Disorders; Taiwan | 2018 |
Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems.
Topics: Benzodioxoles; Central Nervous System Stimulants; Dopamine; HEK293 Cells; Humans; Membrane Transport Proteins; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Pyrrolidines; Serotonin; Synthetic Cathinone | 2019 |
Lab-made solid phase microextraction phases for off line extraction and direct mass spectrometry analysis: Evaluating the extraction parameters.
Topics: Cocaine; Healthy Volunteers; Humans; Jatropha; Lysergic Acid Diethylamide; Methamphetamine; Molecular Imprinting; N-Methyl-3,4-methylenedioxyamphetamine; Pharmaceutical Preparations; Phorbol Esters; Plant Extracts; Polymers; Pyrroles; Saliva; Solid Phase Microextraction; Spectrometry, Mass, Electrospray Ionization; Stainless Steel; Urinalysis | 2019 |
Locomotor sensitization in male Sprague-Dawley rats following repeated concurrent treatment with 4-methylmethcathinone and 3,4-methylenedioxymethamphetamine.
Topics: Animals; Central Nervous System Stimulants; Hallucinogens; Injections, Intraperitoneal; Locomotion; Male; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley | 2019 |
False positive amphetamines and 3,4-methylenedioxymethamphetamine immunoassays in the presence of metoprolol-two cases reported in clinical toxicology.
Topics: Adult; Amphetamine; Amphetamines; Cross Reactions; Female; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Immunoassay; Immunoenzyme Techniques; Male; Methamphetamine; Metoprolol; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection | 2020 |
Quantitative Estimation of 38 Illicit Psychostimulants in Blood by GC-APCI-QTOFMS with Nitrogen Chemiluminescence Detection Based on Three External Calibrators.
Topics: Amphetamine; Benzodioxoles; Calibration; Central Nervous System Stimulants; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; Luminescence; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nitrogen; Pyrrolidines; Substance Abuse Detection; Synthetic Cathinone | 2020 |
Prevalence of self-reported movement dysfunction among young adults with a history of ecstasy and methamphetamine use.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Brain; Cannabis; Central Nervous System Stimulants; Female; Hallucinogens; Humans; Logistic Models; Male; Methamphetamine; Movement Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Self Report; Young Adult | 2019 |
A comparison of trends in wastewater-based data and traditional epidemiological indicators of stimulant consumption in three locations.
Topics: Amphetamine; Cocaine; Data Collection; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Netherlands; Norway; Queensland; Substance Abuse Detection; Wastewater; Wastewater-Based Epidemiological Monitoring | 2020 |
Spatio-temporal assessment of illicit drug use at large scale: evidence from 7 years of international wastewater monitoring.
Topics: Amphetamine; Chromatography, Liquid; Cocaine; Environmental Monitoring; Humans; Illicit Drugs; Internationality; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Spatio-Temporal Analysis; Substance Abuse Detection; Tandem Mass Spectrometry; Wastewater | 2020 |
Development of an addiction index and delineation 15-year trends of illicit drugs from the Taiwan national drug enhancement database.
Topics: Amphetamine-Related Disorders; Anesthetics, Dissociative; Cannabis; Central Nervous System Stimulants; Crime; Databases, Factual; Hallucinogens; Heroin; Humans; Illicit Drugs; Ketamine; Marijuana Abuse; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Opioid-Related Disorders; Psychiatric Status Rating Scales; Substance-Related Disorders; Taiwan | 2020 |
Synthetic cathinones and their phenethylamine analogues produce distinct psychomotor and reward behavior in crayfish.
Topics: Alkaloids; Amphetamines; Animals; Astacoidea; Behavior, Animal; Central Nervous System Sensitization; Central Nervous System Stimulants; Conditioning, Psychological; Male; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Phenethylamines; Reward | 2020 |
[High-risk drug use: epidemiological pattern through hair testing in the forensic context].
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Amphetamine; Cannabinoids; Cocaine; Cross-Sectional Studies; Female; Forensic Sciences; Gas Chromatography-Mass Spectrometry; Hair; Heroin; Humans; Illicit Drugs; Ketamine; Male; Methadone; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Spain; Substance Abuse Detection; Substance-Related Disorders; Young Adult | 2019 |
Methylenedioxymethamphetamine-like discriminative stimulus effects of seven cathinones in rats.
Topics: Acetone; Amphetamines; Animals; Discrimination Learning; Ethylamines; Male; Methamphetamine; Methylamines; N-Methyl-3,4-methylenedioxyamphetamine; Pentanones; Propiophenones; Rats | 2020 |
Differential genetic risk for methamphetamine intake confers differential sensitivity to the temperature-altering effects of other addictive drugs.
Topics: Amphetamine-Related Disorders; Analgesics, Opioid; Animals; Cocaine; Dopamine Agents; Female; Genotype; Hypothermia; Male; Methamphetamine; Mice; Mice, Inbred Strains; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Receptors, G-Protein-Coupled; Receptors, Opioid, mu; Thermosensing | 2020 |
A Retrospective of Prevalence of Drugs of Abuse by Hair Analysis in Shanghai using LC-MS-MS.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamines; Central Nervous System Stimulants; China; Chromatography, Liquid; Cocaine; Female; Hair; Hair Analysis; Humans; Illicit Drugs; Male; Methamphetamine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Retrospective Studies; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry | 2020 |
Stability and Degradation Pathways of Different Psychoactive Drugs in Neat and in Buffered Oral Fluid.
Topics: Amphetamine; Cocaine; Codeine; Drug Stability; Forensic Toxicology; Illicit Drugs; Methamphetamine; Morphine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Psychotropic Drugs; Specimen Handling; Substance Abuse Detection | 2020 |
Synthetic psychoactive cathinones: hypothermia and reduced lethality compared to methamphetamine and methylenedioxymethamphetamine.
Topics: Alkaloids; Animals; Behavior, Animal; Body Temperature Regulation; Central Nervous System Stimulants; Female; Hypothermia; Lethal Dose 50; Locomotion; Male; Methamphetamine; Mice; Mice, Inbred C57BL; N-Methyl-3,4-methylenedioxyamphetamine; Psychotropic Drugs; Seizures; Synthetic Drugs | 2020 |
High ambient temperature increases the toxicity and lethality of 3,4-methylenedioxymethamphetamine and methcathinone.
Topics: Ammonia; Animals; Brain; Central Nervous System Stimulants; Disease Models, Animal; Female; Glutamic Acid; Hot Temperature; Male; Methamphetamine; Mice; Mice, Inbred C57BL; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Propiophenones; Signal Transduction; Substance-Related Disorders | 2020 |
Methamphetamine, Amphetamine, and MDMA Use and Emergency Department Recidivism.
Topics: Adult; Amphetamine; Emergency Service, Hospital; Female; Humans; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Recidivism; Retrospective Studies | 2020 |
Enhancement of the rewarding effects of 3,4-methylenedioxymethamphetamine in orexin knockout mice.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Classical; Gyrus Cinguli; Male; Methamphetamine; Methylphenidate; Mice; Mice, Inbred C57BL; Mice, Knockout; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Orexins; Reward; Serotonin 5-HT1 Receptor Agonists; Spatial Learning | 2021 |
Determination of ketamine, methamphetamine and 3,4-methylenedioxymethamphetamine in human hair by flash evaporation-gas chromatography/mass spectrometry.
Topics: Gas Chromatography-Mass Spectrometry; Hair; Humans; Ketamine; Limit of Detection; Linear Models; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Substance Abuse Detection | 2020 |
Shifts in Unintentional Exposure to Drugs Among People Who Use Ecstasy in the Electronic Dance Music Scene, 2016-2019.
Topics: Adult; Dancing; Drug Contamination; Female; Hair Analysis; Harm Reduction; Humans; Illicit Drugs; Intention; Ketamine; Male; Methamphetamine; Music; N-Methyl-3,4-methylenedioxyamphetamine; Psychotropic Drugs; Substance Abuse Detection; Substance-Related Disorders; Surveys and Questionnaires | 2021 |
Stimulant storm - state health department psychostimulant age-adjusted mortality rate correlates with psychostimulant-based Michigan Poison Center case exposures over time.
Topics: Adult; Amphetamine; Central Nervous System Stimulants; Dextroamphetamine; Drug Overdose; Female; Humans; Linear Models; Male; Methamphetamine; Methylphenidate; Michigan; N-Methyl-3,4-methylenedioxyamphetamine; Opioid-Related Disorders; Poison Control Centers | 2021 |
Reinforcing effects of synthetic cathinones in rhesus monkeys: Dose-response and behavioral economic analyses.
Topics: Alkaloids; Animals; Behavior, Animal; Benzodioxoles; Central Nervous System Stimulants; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Female; Macaca mulatta; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pentanones; Protein Binding; Pyrrolidines; Reinforcement, Psychology; Self Administration; Serotonin Plasma Membrane Transport Proteins; Synthetic Cathinone; Synthetic Drugs | 2021 |
Discriminative-Stimulus Effects of Synthetic Cathinones in Squirrel Monkeys.
Topics: Alkaloids; Animals; Behavior, Animal; Benzodioxoles; Central Nervous System Stimulants; Discrimination Learning; Interoception; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Propiophenones; Psychotropic Drugs; Pyrrolidines; Saimiri; Synthetic Cathinone | 2021 |
Selective filtering of excitatory inputs to nucleus accumbens by dopamine and serotonin.
Topics: Animals; Behavior, Animal; Dopamine; Excitatory Postsynaptic Potentials; Methamphetamine; Mice, Inbred C57BL; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Nucleus Accumbens; Serotonin; Social Interaction; Synaptic Transmission | 2021 |
Determination of the enantiomeric composition of amphetamine, methamphetamine and 3,4-methylendioxy-N-methylamphetamine (MDMA) in seized street drug samples from southern Germany.
Topics: Amphetamine; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Stereoisomerism | 2022 |
Spatial, temporal and socioeconomic patterns of illicit drug use in New Zealand assessed using wastewater-based epidemiology timed to coincide with the census.
Topics: Cocaine; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; New Zealand; Substance Abuse Detection; Wastewater; Wastewater-Based Epidemiological Monitoring; Water Pollutants, Chemical | 2021 |
Out of the night-time and into the day: Ketamine and MDMA as therapies for mental disorders.
Topics: Hallucinogens; Humans; Ketamine; Mental Disorders; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders | 2021 |
Development of a point-of-care test for the detection of MDMA in latent fingerprints using surface plasmon resonance and lateral flow technology.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Gas Chromatography-Mass Spectrometry; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Point-of-Care Testing; Substance Abuse Detection; Surface Plasmon Resonance; Technology | 2022 |
Editorial of special issue - Synthetic psychoactive substances and neurological diseases: Toxic and therapeutic effects.
Topics: Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Psychotropic Drugs; Treatment Outcome | 2022 |
Changes in and correlates of Australian public attitudes toward illicit drug use.
Topics: Australia; Cannabis; Cocaine; Hallucinogens; Heroin; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders | 2022 |
Concerts, bars, parties, and raves: Differential risk for drug use among high school seniors according to venue attendance.
Topics: Adolescent; Central Nervous System Stimulants; Cocaine; Ethanol; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Schools; Substance-Related Disorders | 2022 |
Injecting drug use opportunities and reasons for choosing not to inject: A population-based study of Australian young adults who use stimulants.
Topics: Australia; Central Nervous System Stimulants; Female; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse, Intravenous; Substance-Related Disorders; Young Adult | 2022 |
Pharmacological characterization of 3,4-methylenedioxyamphetamine (MDA) analogs and two amphetamine-based compounds: N,α-DEPEA and DPIA.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Carrier Proteins; Dopamine; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Serotonin | 2022 |
Survey of substance use among adolescent drug offenders referred from juvenile courts in Taiwan: Clinical epidemiology of single versus multiple illicit substance use.
Topics: Adolescent; Criminals; Depressive Disorder, Major; Humans; Illicit Drugs; Ketamine; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nitrous Oxide; Substance-Related Disorders; Taiwan | 2022 |
Enantiomeric profiling of amphetamines in wastewater using chiral derivatisation with gas chromatographic-tandem mass spectrometric detection.
Topics: Amphetamine; Amphetamines; Gas Chromatography-Mass Spectrometry; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2022 |
Use of illicit drugs, alcohol and tobacco in Spain and Portugal during the COVID-19 crisis in 2020 as measured by wastewater-based epidemiology.
Topics: Amphetamine; Cocaine; Communicable Disease Control; COVID-19; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nicotiana; Pandemics; Portugal; Spain; Substance Abuse Detection; Substance-Related Disorders; Wastewater; Wastewater-Based Epidemiological Monitoring; Water Pollutants, Chemical | 2022 |
Trends in methamphetamine use, markets and harms in Australia, 2003-2019.
Topics: Amphetamine-Related Disorders; Australia; Bayes Theorem; Central Nervous System Stimulants; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Seizures | 2022 |
Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid at Concentrations Recommended for the Investigation of DUID Cases.
Topics: 2-Propanol; 3,4-Methylenedioxyamphetamine; Alprazolam; Amphetamines; Buprenorphine; Carisoprodol; Clonazepam; Cocaine; Codeine; Dronabinol; Fentanyl; Hexanes; Hydrocodone; Hydromorphone; Lorazepam; Meprobamate; Methadone; Methamphetamine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Nordazepam; Oxazepam; Oxycodone; Oxymorphone; Pharmaceutical Preparations; Phencyclidine; Tandem Mass Spectrometry; Temazepam; Tramadol; Zolpidem | 2022 |
Relative reinforcing effects of dibutylone, ethylone, and N-ethylpentylone: self-administration and behavioral economics analysis in rats.
Topics: Acetone; Animals; Benzodioxoles; Butylamines; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Economics, Behavioral; Ethylamines; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Self Administration | 2022 |
Illicit drug consumption estimated using wastewater analysis and compared by settlement size in New Zealand.
Topics: Chromatography, Liquid; Cocaine; Fentanyl; Heroin; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; New Zealand; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2022 |
Evaluation of Cytotoxic, Necrotic, Apoptotic, and Autophagic Effects of Methamphetamine and 3,4-Methylenedioxymethamphetamine on U-87 MG (Glial) and B104-1-1 (Neuronal) Cell Lines.
Topics: Acridine Orange; Cell Line; Central Nervous System Stimulants; Designer Drugs; Ethidium; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Necrosis; Propidium; Serotonergic Neurons | 2022 |
Monitoring of changes in illicit drugs, alcohol, and nicotine consumption during Ramadan via wastewater analysis.
Topics: Amphetamine; Cannabis; Cocaine; Ethanol; Heroin; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Substance Abuse Detection; Wastewater; Water Pollutants, Chemical | 2022 |
Amphetamines in Workplace Testing Hair Samples over the Years 2011-2020.
Topics: Amphetamines; Hair; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Workplace | 2023 |
Consumption of common illicit drugs in twenty-one cities in southwest China through wastewater analysis.
Topics: China; Chromatography, Liquid; Cities; Cocaine; Codeine; Heroin; Illicit Drugs; Ketamine; Methamphetamine; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2022 |
Illicit drugs and their metabolites in urban wastewater: Analysis, occurrence and consumption in Xinjiang, China.
Topics: Dronabinol; Illicit Drugs; Methamphetamine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2022 |
Wastewater-based monitoring of illicit drugs in Cyprus by UPLC-MS/MS: The impact of the COVID-19 pandemic.
Topics: Amphetamine; Chromatography, Liquid; Cocaine; Communicable Disease Control; COVID-19; Cyprus; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pandemics; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2023 |
Triangulating Amsterdam's illicit stimulant use trends by wastewater analysis and recreational drug use monitoring.
Topics: Amphetamines; Central Nervous System Stimulants; Cocaine; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Recreational Drug Use; Substance Abuse Detection; Substance-Related Disorders; Wastewater; Water Pollutants, Chemical | 2022 |
Development and initial validation of an MDMA/Ecstasy motives assessment.
Topics: Adult; Affect; Cannabis; Hallucinogens; Humans; Methamphetamine; Motivation; N-Methyl-3,4-methylenedioxyamphetamine | 2023 |
Methylone pre-exposure differentially impacts the aversive effects of MDPV and MDMA in male and female Sprague-Dawley rats: Implications for abuse vulnerability.
Topics: Animals; Benzodioxoles; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Female; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Substance-Related Disorders | 2022 |
Sexualized drug use among men who have sex with men in Madrid and Barcelona: The gateway to new drug use?
Topics: Adult; Child, Preschool; HIV Infections; Homosexuality, Male; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Sexual and Gender Minorities; Sexually Transmitted Diseases; Sildenafil Citrate; Substance-Related Disorders | 2022 |
Pulverization Is a Crucial Step-A Comparative Study of Different Pretreatments in Hair Drug Testing.
Topics: Amphetamine; Hair; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection | 2023 |
Dantrolene sodium fails to reverse robust brain hyperthermia induced by MDMA and methamphetamine in rats.
Topics: Animals; Body Temperature; Brain; Dantrolene; Hyperthermia, Induced; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats | 2023 |
Disruption to Australian heroin, methamphetamine, cocaine and ecstasy markets with the COVID-19 pandemic and associated restrictions.
Topics: Australia; Cocaine; COVID-19; Heroin; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pandemics; Surveys and Questionnaires | 2023 |
An Overview of Adolescent Psychostimulant Use.
Topics: Adolescent; Adult; Central Nervous System Stimulants; Child; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Referral and Consultation; Young Adult | 2023 |
Tusi: a new ketamine concoction complicating the drug landscape.
Topics: Cocaine; Hallucinogens; Humans; Ketamine; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders | 2023 |
Drug-induced social connection: both MDMA and methamphetamine increase feelings of connectedness during controlled dyadic conversations.
Topics: Communication; Emotions; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Oxytocin | 2023 |
Early onset Parkinson's disease in the cycle of 3,4-methylenedioxymethamphetamine and substance use: a case report.
Topics: Adult; Dopamine; Humans; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Parkinson Disease; Substance-Related Disorders | 2023 |
Substance use and variation in sexual partnership rates among young MSM and young transgender women: Disaggregating between and within-person associations.
Topics: Cocaine; Female; HIV Infections; Homosexuality, Male; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Sexual and Gender Minorities; Sexual Behavior; Sexual Partners; Sexually Transmitted Diseases; Substance-Related Disorders; Transgender Persons | 2023 |
Development of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its phase-1 metabolites in human biological fluids.
Topics: 3,4-Methylenedioxyamphetamine; Amylose; Chromatography, High Pressure Liquid; Chromatography, Liquid; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Stereoisomerism; Tandem Mass Spectrometry | 2024 |
Comprehensive evaluation of drug cases in Seoul and its metropolitan areas - 2022.
Topics: Amphetamine; Cannabinoids; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Seoul; Substance Abuse Detection | 2023 |